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In nature proteins evolve by a combination of point mutagenesis and recombination. This 
process has generated hundreds of fascinating and structurally complex protein folds 
capable of performing a myriad of important and diverse biochemical functions. This has 
inspired protein engineers to mimic natural protein evolution in the library to construct 
synthetic proteins with new or improved properties. Here I show that homologous protein 
recombination can be used in the library to engineer novel enzymes with new catalytic 
activities and altered substrate specificities. I also propose that homologous 
recombination can be used in the laboratory to overcome the challenge of improving the 
native activities of wild-type proteins. In nature recombination may have helped proteins 
escape local maxima of the fitness landscape by introducing many homologous mutations 
to which proteins are highly tolerant. Protein engineers can possibly use it for the same 
purpose. I validate this hypothesis computationally with highly simplified protein models, 
and I attempt an experimental verification of this theory with cellulases.  
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The most intricate human-designed machines pale in comparison to the complexity and 
stunning functionality of the proteins created by evolution. The bewildering complexity 
of how protein primary sequences encode these remarkable functions, such as catalyzing 
in a few seconds chemical reactions that would otherwise take millions of years, reveals 
the extraordinary capability of natural evolution to seek out protein sequences encoding 
highly functional molecules from an immense sequence space representing mostly 
unfolded and dysfunctional proteins. 
Natural evolution moves about protein sequence space by single mutational steps 
and by long jumps spanning many mutations via homologous or nonhomologous 
recombination. Evidence of the effectiveness of these mutational moves is abundant and 
ubiquitous in nature: hundreds of different protein folds accounting for an innumerable 
number of biochemical functions makes up much of our living world. The trophies of 
natural protein evolution have inspired engineers to borrow nature’s algorithm to create 
new proteins with novel or improved properties. Here, I focus on homologous 
recombination, and I show that it can be exploited in the laboratory to engineer enzymes 
with novel activities and specificities. Also, I propose that the products of homologous 
recombination, chimeras, may be more evolvable than their parents with respect to the 
native activity because their mutational neighborhood has never been searched by 
evolutionary processes. 
Homologous recombination distinguishes itself from other protein engineering 
strategies (such as point mutagenesis) in that it explores distant regions of sequence 
space: proteins that differ in many tens or even hundreds of amino acids from known 
proteins yet still fold and function can be constructed. Drummond et al. [1] compared 
random mutation to recombination, investigating how the probability of retaining fold (or 
parental function) depends on the number of mutations introduced.  Random mutations 
cause a steep, exponential decay in this probability: as is well appreciated by protein 
engineers and protein scientists, most mutations are deleterious. As chimeras migrate 
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from one functional native sequence to the next, however, the likelihood of preserving 
structure or function follows a parabolic curve whose initial slope is much less steep 
(Figure 1). With data from chimeric and randomly-mutated ß-lactamases, Drummond et 
al. showed that recombination is much more conservative than random mutation, leading 
to a folding probability that is many orders of magnitude greater at the highest mutation 
levels. By exploiting the conservative nature of mutations introduced into a structure that 
has already proven to tolerate them, recombination creates chimeric enzymes that are 
distant from one another in sequence with minimal loss in their probability of folding. 
 
Figure 1: Chimeras occupy a functionally enriched ridge in sequence space. Surface 
height represents the probability of retaining fold as a function of random and 
homologous substitutions.  Substituting amino acids that already exist in a homologous 
protein is much more conservative of structure and function than random substitutions. 
Figure reproduced from [1].  
 
In chapter 1 I describe the first attempt to characterize the diversification of 
catalytic function within a library of SCHEMA [2] chimeras. SCHEMA is a structure-
guided recombination algorithm that selects the crossover locations that maximize the 
average sequence diversity in the library while minimizing structural disruptions (please 
refer to SCHEMA Background at the end of this section for a brief overview of how 
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SCHEMA works). Using structure-guided SCHEMA recombination, Otey et al. [3] 
partitioned the heme domains of cytochrome P450BM3 (CYP102A1) and homologs 
sharing 61-64% sequence identity into eight blocks and recombined those to make 
thousands of chimeric P450s. About 47% of the library encodes a properly folded P450, 
and of those more than 75% are functional. Functional chimeras differ from any known 
parent by up to 101 amino acid mutations (out of 466).  
The inspiration to use homologous recombination to discover new physical and 
enzymatic properties comes from the observation that proteins with identical folds can 
diverge greatly not only in sequence, but also in function. The P450 scaffold represents 
an excellent system to begin this characterization because they comprise a large family of 
enzymes known to exhibit great diversity at the sequence and functional level. Thousands 
of P450 sequences exhibiting nearly identical folds and often only 15-20% sequence 
identity have been reported. They are known to accept many structurally diverse 
substrates ranging from flexible linear chain molecules like fatty acids to rigid planar 
molecules like testosterone. P450s are thus naturally malleable to both sequence and 
functional alterations.  
The high sequence diversity among the folded members of the P450 SCHEMA 
library made this an excellent system to begin probing the functional diversity accessible 
by recombination. We measured the ability of the parents and fourteen chimeric P450s to 
hydroxylate a set of eleven substrates, including four human drugs. In chapter 1 I show 
that the best enzyme on each compound was always a chimera, and some chimeras 
accepted substrates not accepted by any of the parents.  P450s play a major role in drug 
metabolism and are known to bind and hydroxylate the majority of the drugs we intake. 
Soluble, bacterial P450 chimeras that can produce drug metabolites may be useful for 
drug metabolic profiling and lead diversification.  
In chapter 2 I present a theory that proposes that chimeras can be expected to be 
more evolvable than their wild-type parents with respect to the native activity. Improving 
the native activity of wild-type enzymes is a difficult problem to tackle by directed 
evolution because the mutational neighborhood of native proteins has already been 
searched by natural evolution. I propose that chimeras have access to a greater number of 
beneficial mutations than their native parents because their mutational neighborhood is 
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unexplored. This argument trivially holds true for chimeras that are less fit than their 
parents but should also hold for chimeras that are as fit as their parents. Since 
homologous recombination can introduce many mutations without disrupting folding and 
function, chimeragenesis may help resolve the problem of improving native activities. 
The underlying assumption of this theory is that the constraints that prevent the 
improvement of native activities are evolutionary rather than biophysical or biochemical 
(i.e., native enzymes are locally rather than globally optimized). The hypothesis is that 
chimeragenesis provides a means of escape from these local optima and gives chimeras 
access to beneficial mutations that are not accessible to their wild-type counterparts. I 
validate this theory in the context of lattice proteins which are highly simplified models 
of a protein consisting of a chain of 20 monomers on a two-dimensional lattice, and I 
discuss the requirements that must be satisfied for these results to hold true in the context 
of real enzymes.  
In chapter 3 I test the theory of chapter 2 on real cellulase chimeras assembled by 
SCHEMA recombination of the catalytic domains of Cel6A from Trichoderma reesei and 
its homologs from Humicola insolens and Chaetomium thermophilum. Cellulases 
represent a good system to begin testing this theory because while it is extremely 
desirable to improve their native cellulolytic activity, to date, no one has reported 
significant enhancements of their specific activity suggesting that the mutational 
neighborhood of these enzymes does not contain beneficial mutations. Furthermore, the 
existence of other glycoside hydrolases performing similar chemistry but exhibiting kcat 
values that are several orders of magnitude greater than those of cellulases suggests that 
these enzymes may be locally rather than globally optimized. The SCHEMA library 
represents a great opportunity to test the theory of chapter 2 because it contains many 
members that are heavily mutated and yet retain wild-type activities.  
The mutational neighborhood of several cellulase chimeras was explored by 
random point mutagenesis to determine whether beneficial mutations not accessible to 
their parents could be found. Unfortunately only weakly beneficial mutations 
representing specific activity improvements comparable to those already reported in the 
literature were found. The lack of beneficial mutations in the mutational neighborhood of 
the selected chimeras my reflect either 1) an unlucky choice of chimeras, 2) a high degree 
  
5 
of amino acid conservation in the functionally important regions of the parental enzymes, 
3) a low frequency of beneficial mutations in the entirety of sequence space, and 4) a 
physical limitation to further improvements (i.e., the native enzymes are globally 





Proteins are naturally robust to homologous mutations (Figure 1). Computational 
methods that exploit structural information can be used to further increase the probability 
that homologous mutations are tolerated and thus optimize the design of recombination 
libraries. This is effectively equivalent to raising the ridge connecting the two parents of 
Figure 1. These algorithms generally aim to simultaneously maximize the sequence 
diversity and the structural integrity of chimeric proteins.  
My work is based on chimeras designed using the structure-guided recombination 
algorithm, SCHEMA [2]. SCHEMA is an algorithm that scores chimeras based on the 
assumption that nonnative contacts are, on average, deleterious to structure and function. 
The SCHEMA score, E, is thus equal to the number of nonnative contacts in any given 
chimera. The algorithm uses the high-resolution crystal structure of one parent to identify 
all amino acid pair-wise contacts as defined by a 4.5 Å structural cutoff. For any given 
chimera, the algorithm assumes that its three-dimensional structure will be identical to 
that of the parent and counts the number of non-native contacts. Nonnative contacts can 
only form when the two contacting residues are inherited from different parents and when 
both residues are not perfectly conserved among the parents as shown in Figure 2. An 
optimization algorithm, RASPP, then directs crossovers to locations that minimize the 
average disruption in the library while maintaining high diversity [4]. The crossover 
locations are fixed, such that there exist 38 = 6,561 possible sequences in a design based 
on three parents and seven crossovers. According to this framework, the interfaces 
between the recombination fragments are composed primarily of conserved residues. 
Meyer et al. [5] showed that among chimeras with similar numbers of mutations, those 
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with lower SCHEMA scores are more likely to function validating the physical 




Figure 2: Demonstration of how SCHEMA scores chimeras in a hypothetical 12-residue 
peptide. Grey residues are conserved in the parents, blue and red residues represent non-
conserved amino acids in parents 1 and 2 respectively. Contacting residues (based on the 
4.5 Å cutoff of the hypothetical crystal structure of the peptides) are connected by a black 
solid line shown only in parent 1. Crossovers locations are marked by a short black 
segment in the chimeras. The SCHEMA score, E, is equal to the number of nonnative 
contacts in each chimera.
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A version of the chapter has been published in [6] 
1.1 Abstract 
We report initial characterization of a synthetic family of more than 3,000 cytochrome 
P450s made by SCHEMA recombination of three bacterial CYP102s. Sixteen heme 
domains and their holoenzyme fusions with each of the three parental reductase domains 
were tested for activity on eleven different substrates. The results show that the chimeric 
enzymes have acquired significant functional diversity, including the ability to accept 
substrates not accepted by the parent enzymes. K-means clustering analysis of the 
activity data allowed the enzymes to be classified into five distinct groups based on 
substrate specificity. The substrates can also be grouped, such that one can be a 
‘surrogate’ for others in the group. Fusion of a functional chimeric heme domain with a 
parental reductase domain always reconstituted a functional holoenzyme, indicating that 
key interdomain interactions are conserved upon reductase swapping.  
 
1.2 Introduction 
Enzymes with altered activities and specificities can be generated in the laboratory by 
processes that mimic mechanisms of natural evolution. Directed evolution combining 
recombination and random point mutation (e.g. DNA shuffling) is effective in generating 
both genotypic and phenotypic novelty [7-13]. Although recombination can make many 
mutations with relatively little structural disruption [14], we do not know the degree of 
functional diversity that is accessible to a process that only explores combinations of 
mutations already accepted during natural evolution. 
We recently reported construction of a synthetic family of more than 3,000 
properly folded cytochrome P450 heme domains [15]. Assembled by structure-guided 
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recombination of the heme domains of CYP102A1 from Bacillus megaterium (A1) and 
its homologs CYP102A2 (A2) and CYP102A3 (A3) that exhibit ~65% amino acid 
identity, the chimeric proteins differ from the parent sequences by 72 out of 463–466 
amino acids on average. Our current goal is to understand how this sequence 
diversification relates to diversification of function. Initial studies [15,16] demonstrated 
that recombination, in the absence of point mutations, can generate functional features 
outside the range exhibited by the parental P450s. For example, a chimeric heme domain 
significantly more thermostable than any of the parents was identified (T50 = 62°C versus 
55°C for the most stable parent) [15]; subsequent analysis of more than 200 chimeric 
heme domains identified many thermostable proteins [17]. Our previous study of selected 
chimeras of the A1 and A2 heme domains showed that chimeragenesis could also 
generate activities not exhibited by the parents [16], as has also been reported for 
recombination of mammalian P450s [18,19].  
The biological functions of cytochrome P450s include key roles in drug 
metabolism, breakdown of xenobiotics, and steroid and secondary metabolite 
biosynthesis [20]; members of the P450 superfamily catalyze hydroxylation and 
demethylation reactions on a vast array of substrates [21]. Enzymes from the synthetic 
P450 family could be useful catalysts for synthesis of biologically-active compounds if 
they have acquired the ability to accept substrates not accepted by the parent enzymes 
(which are all fatty acid hydroxylases). Identifying particular desired products, however, 
usually requires protein purification and HPLC and/or MS analysis, methods that are 
cumbersome when testing hundreds of biocatalysts. Thus, in addition to exploring the 
range of catalytic activities in the chimeric P450 family, a second goal of the current 
study is to determine to what extent ‘surrogate’ substrates can be used to identify likely 
catalyst candidates for a particular reaction in a high-throughput screening mode. Can 
substrates be grouped in such a way that activity towards one member of a group can be 
used to predict activity towards another? 
Enzymes of the CYP102 family are comprised of a reductase domain and a heme 
domain connected by a flexible linker [22,23]. With a single amino acid substitution 
(F87A in A1 and F88A in A2 and A3), the heme domains can function alone as 
peroxygenases, catalyzing oxygen insertion in the presence of hydrogen peroxide [24]. 
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The synthetic CYP102A family was constructed from parental sequences containing this 
mutation; all of the chimeric proteins can therefore potentially function as peroxygenases. 
We are also interested in their ability to be reconstituted into functional monooxygenases, 
utilizing NADPH and molecular oxygen for catalysis, by fusion to a reductase domain. 
The reductase domain of CYP102A1 (R1) spans ~585 amino acids and encodes a ~20 
amino acid linker and the binding domains for the FMN, FAD and NADPH cofactors 
[23]. The reductases from CYP102A2 and CYP102A3 (R2 and R3) share 52-55% 
sequence identity with R1 and are comparable in size, the only notable difference being a 
linker region that is extended in R2 by seven amino acids [25]. Because the chimeric 
heme domains comprise sequences from three different parents, it is not obvious that 
fusion to wildtype reductase will generate a catalytically active holoenzyme, nor is it 
clear which reductase, R1, R2 or R3, should be used. For this initial characterization we 
therefore selected a set of 14 chimeric heme domains, reconstituted them with all three 
parental reductase domains, and determined peroxygenase and monooxygenase activities 
on eleven substrates. These activities have been analyzed to 1) assess the functional 
diversity of the chimeric enzymes, 2) determine whether substrates fall into groups for 
the purposes of predicting activities, and 3) compare the activities and specificities of the 
chimeric peroxygenases with those of their reconstituted monooxygenases. 
 
1.3 Results  
1.3.1 Cloning and Expression of P450 Heme Domains and Holoenzymes 
Seventeen heme domains, including the three parent heme domains, were chosen for 
holoenzyme construction by fusion to a wild-type CYP102A reductase domain. For each 
heme domain, four proteins were examined—the heme domain and its fusion to each of 
the three reductase domains—for a total of 68 constructs. Heme domains contain the first 
463 amino acids for A1 and the first 466 amino acids for A2 and A3. The reductase 
domains start at amino acid E464 for R1, K467 for R2 and D467 for R3 and encode the 
linker region of the corresponding reductase. A3 and its fusions with R1 and R2 
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expressed very poorly, yielding only a very small amount of protein after purification, 
and were therefore not analyzed further. 
The chimeric sequences are reported in terms of the parent from which each of the 
eight sequence blocks is inherited (Supplemental Table 1.S1). Twelve of the fourteen 
chimeras were selected because they displayed relatively high activities on substrates in 
preliminary studies (data not shown). Chimera 23132233 was chosen because it displayed 
low peroxygenase activity, while 22312333 was selected because it is more thermostable 
than any of the parents (T50 = 62°C) [15]. For the constructs studied here, the reductase 
identity is indicated as the ninth sequence element, with R0 referring to no reductase (i.e., 
heme domain peroxygenase). 
 
1.3.2 Activity Assays 
To assess the functional diversity of the chimeric P450s, we measured their activities on 
the eleven substrates shown in Figure 1.1. Propranolol (PR), tolbutamide (TB) and 
chlorzoxazone (CH) are drugs that are metabolized by human P450s [9,26,27]. 12-p-
nitrophenoxycarboxylic acid (PN) is a long-chain fatty acid surrogate; parent A1-R1 
holoenzyme and the A1 heme domain (with the F87A mutation) both show high activity 
on this substrate. Previous work showed that A1 has weak peroxygenase activity on some 
of the aromatic substrates [16]. Aromatic hydroxylation products of all substrates can be 
detected quantitatively using the 4-amino antipyrine assay [28]. PN hydroxylation can be 




Figure 1.1: Chemical structures and abbreviations. Substrates are grouped according to 
the pair-wise correlations (see text for details). Members of a group are highly correlated; 
intergroup correlations are low. 
 
Peroxygenase activities of the 16 heme domains (all except A3) were determined 
by assaying for product formation after a fixed reaction time in 96-well plates (see 
Experimental). Similar assays were used to determine monooxygenase activities for each 
of the fusion proteins. Final enzyme concentrations were fixed to 1 µM in order to reduce 
large errors associated with low expression and to allow us to compare chimera activities 
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using absorbance values directly. Protein concentrations were reassayed in 96-well 
format and determined to be 0.88 µM +/- 13% (SD/average). All samples were prepared 
and analyzed in triplicate, and outlier data points were eliminated. Supplemental Tables 
1.S2 and 1.S3 report the averages and standard deviations for each of the assays. More 
than 85% of the data for each substrate was retained, and more than 95% was retained for 
6 of the 11 substrates (Supplemental Table 1.S4).  
Because extinction coefficients are not known for the reaction products, we do not 
report absolute enzyme activities, nor do we report substrate specificities, which are 
ratios of enzyme activity on one substrate to activity on another. Our data nonetheless 
allow us to compare the chimeras with respect to their activities on a given substrate and 
also to compare their activity profiles and therefore their specificities. Chimeras having a 
similar profile form the same relative amounts of products from all substrates and are 
therefore likely to have similar specificities. To better visualize differences among 
chimeras, the highest average absorbance value for a given substrate was set to 100%, 
and all other absorbances for the same substrate, but different chimeras, were normalized 
to this. Figure 1.2 is a heat plot of the complete data set of normalized absorbances, while 





Figure 1.2: Summary of normalized activities for all 56 enzymes acting on 11 substrates. 
Activities are shown using a color scale (white indicating highest and black lowest 
activity), with columns representing substrates and rows representing proteins. Not-
analyzed A3, A3-R1 and A3-R2 proteins are shown in grey. Protein rows are ordered by 
their chimeric sequence first, and then by heme domain (R0) and R1-, R2- and R3-
fusions. 
 
1.3.3 Activities of Parent Enzymes 
Figure 1.3A shows the normalized substrate-activity profiles of the A1 and A2 
peroxygenases. Both have relatively low or no activity on any of the substrates except 
PN, where A1 makes about an order of magnitude more product than does A2. Profiles 
for the reconstituted parent holoenzymes are shown in Figure 1.3B. Fusion of A1 and R1 
generated an enzyme with profile peaks on ethyl 4-phenylbutyrate (PB) and PN. A1 is in 
fact the second-best-performing enzyme on PB. The A1 peroxygenase activity on this 
substrate, however, is among the worst, showing that peroxygenase specificity does not 
necessarily predict that of the monooxygenase. Fusion of A2 to R2 slightly increased 
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activity relative to A2, but did not alter the profile. The A3-R3 holoenzyme exhibits some 
activity on the drug-like substrates (PR, TB, CH) as well as PN and PB.  
Fusion of the A1 and A2 heme domains to other reductase domains yields 
holoenzymes that are active on some substrates (Figures 1.3C and 1.3D). The A2 fusions 
have relatively low activities. A1 fusions with R1 and R2, on the other hand, created 
highly active enzymes with different specificities: the A1-R1 profile has peaks on PN and 
PB, while that of A1-R2 has peaks on PB, phenoxyethanol (PE) and zoxazolamine (ZX). 
The A1-R3 fusion is less active on nearly all substrates.  
 
 
Figure 1.3: Substrate-activity profiles for parent heme domain mono- and peroxygenases.  
Panel A shows parent peroxygenases, panel B parent holoenzyme monooxygenases 
profiles, panel C the A1 protein set and panel D the A2 protein set. In A and B the color 
indicates the origin of the heme domain (Green = A1; Red = A2; Blue = A3). The protein 
set in panel C includes the heme domain A1 (blue) or its R1- (purple), R2- (yellow) or 
R3-fusion (turquoise) protein. Panel D depicts the A2 protein set. 
 
1.3.4 Activities of Chimeras and Identification of Chimera Clusters 
The fourteen chimeric heme domains generated 56 chimeric peroxygenases and 
monooxygenases. Nearly all the chimera fusions outperformed even the best parent 
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holoenzyme, and chimeric peroxygenases consistently outperformed the parent 
peroxygenases (Figure 1.2 and Supplemental Figure 1.S2). The best enzyme for each 
substrate is listed in Supplemental Table 1.S5. All the best enzymes are chimeras. Most 
of the best enzymes are also holoenzymes—only PE has a peroxygenase as the best 
catalyst. 
We now show that there exists a discrete set of characteristic substrate-activity 
profiles to which each chimera can be uniquely assigned. A k-means clustering analysis 
was applied to the normalized absorbance data to better understand the functional 
diversity. K-means clustering, a statistical algorithm that partitions data into clusters 
based on data similarity [30], has been used by Mannervik and co-workers to identify 
groups of mutants exhibiting similar substrate specificities [31] and by others to identify 
protein fragments (4-7 residues) of similar structure [32] and interacting nucleotide pairs 
with similar three dimensional structures [33]. For our analysis, the normalized data were 
used to ensure that each of the 11 dimensions is given equal weight by the clustering 
algorithm. The clustering was performed over values of k (number of clusters) ranging 
from k = 2 to k = 8. The highest silhouette value (see Experimental) was observed at k = 
5. 
The cluster composition for k=5 is depicted in Figure 1.4. Cluster 1, consisting of 
chimeras 32312333-R1/R2 and 32313233-R1/R2 (Figure 1.4B), is characterized by low 
relative activities on CH, TB, PR and PN and high relative activities on all other 
substrates. In fact, two of these chimeras are the best enzymes on all the remaining 
substrates except PB and PE. 
Cluster 2 is made up of 22213132-R2, 21313111-R3, 21313311-R3, which are the 
most active enzymes on TB, CH, and PR (Figure 1.4C). Cluster 2 enzymes are entirely 
inactive on PN and show low activity on most of the substrates that cluster 1 enzymes 
accept (PE, DP, PA, and EB). Relative activities on the remaining substrates (i.e., PB, 
ZX, and PT) are moderate (although lower than cluster 1 chimeras). An exception is 
21313111-R3, which is the best enzyme for PB and also fairly good on PE and DP.  
Cluster 3 contains chimeras A1-R1/R2, 12112333-R1/R2, 11113311-R1/R2, and 
22213132-R1 (Figure 1.4D). The A1-like sequences are characterized by high relative 
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activity on PN (on which 11113311-R1/R2 and A1-R1 are the three top-ranking 
enzymes), and moderate to high relative activity on PB and moderate activity on PE.  
Cluster 4 contains 21313111-R1/R2, 22313233-R2, 22312333-R2, 32312231-R2, 
32312333-R0, 32312333-R3, 32313233-R0, and 32313233-R3 (Figure 1.4E). This 
cluster is characterized by having the highest relative activity on PE, in addition to 
moderate activities on PT, DP and ZX. The remaining chimeras appear in a fifth cluster 
with relatively low activity on everything except PN and PE (Figure 1.4F). This cluster 
contains parental sequences A1-R0, A1-R3, A2-R0, A2-R1/R2/R3 and A3-R3. Native 
sequences are thus only found in two of the clusters. The remaining clusters (1, 2 and 4) 
are made up of highly active chimeras that have acquired novel profiles. 
The partition created by the clustering algorithm shows that the presence and 
identity of the reductase can alter the activity profile and thus the specificity of a heme 
domain sequence. For example, the R1 and R2 fusions of 32312333 and 32313233 
appear in cluster 1, whereas their R0 and R3 counterparts are in cluster 4. Sequences 
22213132 and 21313111 also behave differently when fused to different reductases. 
22213132-R2, for example, displays pronounced peaks on substrates TB, CH and PR that 
are not present in the corresponding peroxygenase and R1/R3 profiles (Supplemental 
Figure 1.2E) and is thus the only member with this heme domain sequence appearing in 
cluster 2. 21313111-R3 and 21313111-R2/R1 have nearly opposite profiles 
(Supplemental Figure 1.S2J) and consequently appear in different clusters. Thus the best 




Figure 1.4: K-means clustering analysis separates chimeras into five clusters. All 
protein-activity profiles are depicted in A, where the color identifies the cluster. Panels B 
through F show profiles for sequences within each cluster. Panel B depicts 32312333-
R1/R2, 32313233-R1/R2. Panel C depicts 22213132-R2, 21313111-R3, 21313311-R3. 
Panel D depicts A1-R1/R2, 12112333-R1/R2, 11113311-R1/R2 and 22213132-R1. Panel 
E depicts 21313111-R1/R2, 22313233-R2, 22312333-R2, 32312231-R2, 32312333-R0, 




1.3.5 Peroxygenase Versus Monooxygenase Activities 
As shown in Figure 1.2, each of the 14 chimeric heme domains can be fused to a parental 
reductase to generate a functional monooxygenase. The resulting monooxygenases are 
generally more active under these conditions than the corresponding peroxygenases (see 
Supplemental Figure 1.S2). The R1 and R2 fusions tend to outperform R3 fusions. While 
altering reductase identity never completely deactivates the protein, it does affect 
specificity in some cases. To quantify the differences between the profiles of the four 
different enzymes that can be made from a given chimera, the pair-wise linear 
coefficients (R2) of the R0/R1, R0/R2, R0/R3, R1/R2, R1/R3 and R2/R3 profiles were 
determined for each heme domain sequence (with the exception of A3). The results are 
shown in Supplemental Table 1.S1. High correlations represent enzyme pairs with similar 
specificities. The results show that peroxygenase and monooxygenase specificities are 
usually different, R1/R2 fusions of a chimera are often very similar (five pairs have R2 
values above 0.9), and the R1 and R2 fusions are less similar to the R3 enzymes.  
 
1.3.6 Identification of Substrate Groups 
To understand whether a chimera’s activity on one substrate predicts activity on another, 
the pair-wise correlations of the absorbances of all the possible substrate pairs were 
determined (Supplemental Table 1.S5). Mannervik and co-workers used correlations 
between activities on substrate pairs to identify enzyme variants with novel substrate 
specificities [13]. Here we use these correlations instead to identify substrates having 
similar chimera profiles. This analysis led to the identification of three substrate clusters 
characterized by high values of the correlation coefficients. Members of different clusters 
are poorly correlated. DP, PT, PA and EB all exhibit high correlations with each other 
(R2 = 0.71-0.92, see Supplemental Figure 1.S1A for an example) and were grouped into 
the core of substrate group A. Group B consists of CH, TB and PR. The categorization of 
this group is clearly defined: its members show high correlations with each other (R2 
above 0.9, see Supplemental Figure 1.S1B for an example), but correlate very poorly 
with the other substrates (R2 = 0.01-0.37). PN does not correlate significantly with any of 
the other substrates tested (R2 = 0.00-0.08) and is its own substrate group C. 
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ZX, PB and PE show moderate correlation to members of the group A core (R2 = 
0.56-0.66, 0.39-0.56 and 0.35-0.61, respectively). These substrates are considered loosely 
associated with group A since they do not belong to any other group due to poor 
correlation with each other and the remaining substrates. 
There exists a correspondence between the chimera clusters and the substrate 
groups. Group A core substrates have cluster 1 chimeras as their top-performing 
enzymes, whereas substrates of group B have cluster 2 chimeras as their top-performing 
enzymes. The top catalysts for group C are three of the cluster 3 chimeras. Members of a 
substrate group thus share the same best-performing enzymes. 
 
1.4 Discussion 
1.4.1 SCHEMA Recombination Creates a Family of Functionally Diverse 
Enzymes 
We have begun to characterize the functional diversity in a synthetic P450 family created 
by structured-guided recombination of bacterial fatty acid hydroxylases. The folded 
P450s, which make up almost 50% of the 6,561 sequences in the SCHEMA library, 
contain an average of 72 mutations from their closest parent. A large fraction of the 
folded P450s were shown to be catalytically active [15], but they had been systematically 
studied on only a single substrate (PN). We therefore selected 11 substrates for this initial 
characterization of 14 of the active chimeric heme domains and their fusions with each of 
the three parental reductase domains. Although most of the parental enzyme constructs 
are poorly active on the selected substrates, many of the chimeras are significantly more 
active. In fact, for every single substrate, including one widely used to assay CYP102A1 
(PN), the top-performing enzyme is a chimera. Recombining mutations already accepted 
in natural homologs thus leads to a family of highly active enzymes that accept a broader 




1.4.2 Chimeras Can be Clustered by Substrate Specificity 
We further showed that the chimeric enzymes exhibit distinct specificities and that they 
can be partitioned into clusters based on their specificity. One cluster contains parent A1-
R1 and all chimeras with A1-like profiles. Another cluster contains low activity chimeras 
and includes all remaining parental sequences. The remaining clusters represent highly 
active chimeras that have acquired new specificities. Members of a cluster are likely to 
exhibit common structural, physical or chemical features that account for their similar 
catalytic properties. If the library is large enough, statistical techniques can be used to 
determine how sequence elements relate to the observed profiles. In particular, if there 
are sufficient numbers of chimeras in each cluster, then powerful tools such as logistic 
regression or machine learning can be used to predict which cluster an untested sequence 
belongs to [15]. This type of analysis would enable the prediction of substrate profiles of 
untested chimeras based on sequence information alone. The functionally diverse 
enzymes generated by SCHEMA-guided recombination can therefore be used to probe 
the sequence and structural basis of enzyme specificity. We recently observed the success 
of such an approach in predicting the thermostabilities of untested chimeras [Yougen Li, 
et al. unpublished data]. Although the current data set does not contain enough sequences 
for a comprehensive analysis of sequence-function relationships, anecdotal observations 
can be used to generate hypotheses for further testing. For example, the chimeras in the 
library with parent A1 in blocks 1, 3 and 4 are all among the best enzymes for PN. These 
same enzymes display low relative activity on all the remaining substrates except for PB. 
This suggests that having parent A1 sequence at one or more of these blocks improves 
PN activity and specificity. 
 
1.4.3 Substrates Fall into Groups that Correlate with Chimera Clusters 
We were also able to partition the substrates into groups based on the linear correlations 
of substrate pairs. An enzyme active on one member of a substrate group is therefore 
likely to be active on another member of the same group. One group consists of the drug-
like substrates TB, PR and CH (Figure 1.1). Another consists of PT, PA, EB and DP. If 
these correlations hold for the larger library of chimeric enzymes, we should be able to 
  
21 
predict with reasonable accuracy the relative activities of a chimera on all the substrates 
in a group by testing activity on only one. This type of analysis can be expanded to a 
larger collection of substrates to identify additional groups or additional members of an 
existing group.  
The observed correspondence between the three substrate groups and chimera 
clusters 1, 2 and 3 illustrates that each group can be associated with a cluster made up of 
or containing the top-performing enzymes for the substrates in that group. Some degree 
of correspondence can be expected, given how the partitions were constructed. However, 
because intra-group correlations are not one and inter-group correlations are not zero, the 
correspondence is not perfect. For this reason there exist chimeras whose profiles exhibit 
peaks on only certain members of a group (cluster 4) and others that exhibit peaks on 
members of different groups (cluster 2 and 3 chimeras). Cluster 4 chimeras have peaks on 
only certain members of group A and are thus responsible for the lower correlations 
among group A substrates. Some cluster 2 and cluster 3 chimeras exhibit peaks on PB (on 
the edge of group A) as well as group B and C, respectively. In fact although PB 
correlates mostly with group A core substrates it shares its top-performing enzymes with 
groups B and C and thus displays a hybrid behavior. This is why PB correlates less with 
group A than core substrates do and why it has higher correlations with group B and C 
members than any other substrate not belonging to these groups.  
Because chimeras displaying high relative activity have more weight in 
determining the correlation coefficients, the top enzymes for one member of a substrate 
group will usually be among the top ones for all members of that group. The clearer the 
definition of the substrate groups, the more likely this is to hold. Given the many 
important applications of P450s in medicine and biocatalysis, and the lack of high-
throughput screens for many compounds of interest, an approach to screening that is 
based on carefully chosen ‘surrogate’ substrates could significantly enhance our ability to 
identify useful catalysts. Clearly, any member of a well-defined substrate group can be a 
surrogate for other members of that group. Further analysis may also help to identify the 
critical physical, structural or chemical properties of substrates belonging to a known 




1.4.4 Swapping Reductase Domains Consistently Yields Active 
Monooxygenases and Conserves Key P450-Reductase FMN Domain 
Interactions 
The literature reports multiple cases in which functional P450s have been reconstituted 
with new reductase domains. In several studies, swapping reductases improved 
mammalian P450 activity [34-36]. A self-sufficient chimeric mammalian P450 2E1 
enzyme was constructed by fusing the 2E1 heme domain to the CYP102A1 reductase 
[37]. Functional chimeras of CYP102A1 and the flavocytochrome nitric oxide synthase 
(nNOS) have been generated [38]. Another study reported the functional expression of 
CYP153A genes by incorporating them into a framework consisting of the N- and C- 
termini of homolog CYP153A13a and fusion to the reductase domain of CYP116B2 [39].  
Reconstitution of the chimeric CYP102A heme domains with the three parental 
reductases generated functional monooxygenases in all cases. Although their specificities 
were often different (particularly when fused to R3), fusion to a reductase was never 
detrimental to activity, and swapping the reductase never completely inactivated the 
enzyme (Supplemental Figure 1.S2). Subtle changes in the structure and coupling 
behavior that affect total product formation may account for specificity differences. The 
fact that the parental reductase domains are accepted without loss of function, however, 
suggests that key domain-domain interactions are conserved upon reductase swapping.  
Although a complete crystal structure of a CYP102A holoenzyme is not available, 
a partial CYP102A1 structure (1BVY) includes the interface between the heme and the 
reductase FMN domains. Only a few direct contacts, including one hydrogen bond, one 
salt bridge and several water-mediated contacts, make up this A1-R1 interface [40]. We 
aligned the parental sequences using ClustalW [41] and found that the interactions 
depicted in the 1BVY crystal structure involve amino acids that are mostly conserved in 
the parent proteins. Figure 1.5 displays the interface between the heme and reductase 
domains of CYP102A1 and highlights the amino acids involved in key interactions. The 
salt bridge is formed between reductase residue E494 and heme domain residue H100, 
both of which are conserved in all three parents. Thus this key interaction would be 
retained upon reductase swapping that conserves the orientation of the two domains. 
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The direct hydrogen bond occurs between the reductase backbone carbonyl of 
N573 and the side-chain hydroxyl group of heme domain residue S383. N573 is only 
conserved in R1 and R2, but because the interaction involves the backbone oxygen, the 
reductase side of the interface is not affected by changes in the side-chain identity. S383 
is only conserved in parents A1 and A3. However, the corresponding residue in A2, 
D385, may also be capable of forming the hydrogen bond. This interaction may therefore 
be present in all the chimeras.  
There are two water-mediated hydrogen bonds between the hydrogen of the 
indole nitrogen of reductase residue W574 and the backbone carbonyl of S383 and I385. 
W574 was earlier shown to be crucial for electron transfer from the FMN to the heme 
[42] and is conserved in R1, R2 and R3. S383 and I385 are conserved in A1 and A3 but 
not A2, where the corresponding residues are D385 and V387. Because the hydrogen 
bonds involve the backbone oxygens of these residues, these interactions may be retained 
upon domain substitution. Also, all possible pair-wise interactions that can be formed at 
these positions by domain swapping already exist in at least one of the parental sequences 
and are thus likely not to be destabilizing. Finally, the substitutions that do occur are 
conservative, replacing a hydrophilic residue with another hydrophilic residue and a 
hydrophobic residue with another hydrophobic residue. The third water-mediated 
hydrogen bond between the side chains of reductase residue R498 and heme domain 
residue E244 (block 5) is conserved in A1-R1, A2-R2 but not A3-R3, where the 
corresponding residues are G501 and V246. A3-R3 thus cannot form this interaction nor 
can any chimera that inherits A3 sequence at block 5 and/or is fused to R3. 
 In summary, it appears that the direct hydrogen bond, two of the three water-
mediated hydrogen bonds and the salt bridge are all conserved in the chimera-reductase 
fusions. The third water-mediated hydrogen bond is conserved only in R1/R2 fusions that 
do not have parent A3 in block 5 (8 out of 17 sequences). Thus the activities of the 
reconstituted monooxygenases are consistent with their sequences, the domain-domain 
interactions identified in the 1BVY structure and the assumption that the overall 
structures and orientations are conserved upon reductase swapping. These results 
demonstrate the highly conservative nature of mutation by recombination of protein 
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domains: as long as key interactions are retained, the remaining sequences can vary 
extensively. 
 
Figure 1.5: Interface between the FMN (blue backbone) and heme domain (brown 
backbone) based on the 1BVY structure redrawn according to Sevrioukova et al. [40]. 
Residue colors indicate the degree of conservation: red (three parents), turquoise (two 
parents) and green (not conserved). Hydrogen bonds are shown as dashed lines. The 




The evolvable cytochrome P450 scaffold has diversified over millions of years of 
mutation and natural selection to exhibit the myriad activities of the natural enzyme 
family, of which more than 4,500 sequences are known [44]. We constructed a large 
synthetic P450 family by recombining sequence elements from three bacterial P450s 
[15]. We have now shown that members of this synthetic family exhibit diverse activities 
and specificities, including activities towards substrates that are not accepted by the 
parent P450s and drug-like compounds that are substrates of human P450s. Thus 
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enzymes in this family have acquired the ability to mimic important reactions in human 
drug metabolism. The grouping of substrates according to likelihood that a given chimera 
will accept them, as has been demonstrated here, will aid in the identification of useful 
catalysts from this synthetic family by high-throughput screening of substrate 
‘surrogates’. We anticipate that these enzymes will be useful for synthesis of drug 
metabolites [26], as needed for toxicity testing and drug discovery.  
 
1.6 Experimental Methods 
1.6.1 Nomenclature and Construction of Holoenzymes from Chimeric Heme 
Domains 
Details of chimera construction have been reported previously [15]. Sequences are given 
an eight-digit number, where each digit indicates the parent from which each of the eight 
blocks was inherited. The identity of the reductase is indicated by R0 (for no reductase) 
or R1, R2 or R3 for the CYP102A1, A2, or A3 reductases, respectively. 
To construct the holoenzymes, the chimeric heme domains were fused to each of 
the three wild-type reductase domains after amino acid residue 463 when the last block 
originates from CYP102A1 and 466 for CYP102A2 and CYP102A3. The holoenzymes 
were constructed by overlap extension PCR [45] and/or ligation and cloned into the 
pCWori expression vector [46]. All constructs were confirmed by sequencing.  
 
1.6.2 Protein Expression and Purification 
Proteins were expressed in E. coli as described previously and purified by anion 
exchange on Toyopearl SuperQ-650M from Tosoh [47]. After binding of the proteins, the 
matrix was washed with a 30 mM NaCl buffer, and proteins were eluted with 150 mM 
NaCl (all buffers used for purification contained 25 mM phosphate buffer pH 8.0). 
Proteins were rebuffered into 100 mM phosphate buffer and concentrated using 30,000 
MWCO Amicon Ultra centrifugal filter devices (Millipore). Proteins were stored at          
-20°C in 50% glycerol. 
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Protein concentration was measured by CO absorption at 450 nm as described 
[48]. A protein concentration of 1 µM was chosen for the activity assays. Protein 
concentrations were reassayed in 96-well format and determined to be 0.88 µM +/- 13% 
(SD/average).  
 
1.6.3 Functional Assays 
Proteins were assayed for mono- or peroxygenase activities in 96-well plates as described 
[15,49]. Heme domains were assayed for peroxygenase activity using hydrogen peroxide 
as the oxygen and electron source. Reductase domain fusion proteins were assayed for 
monooxygenase activity, using molecular oxygen and NADPH. Reactions were carried 
out in 100 mM EPPS buffer pH 8, 1% acetone, 1% DMSO, 1 µM protein in 120 µl 
volumes. Substrate concentrations depended on their solubility under the assay 
conditions. Final concentrations were: 2-phenoxyethanol (PE), 100 mM; ethoxybenzene 
(EB), 50 mM; ethyl phenoxyacetate (PA), 10 mM; 3-phenoxytoluene (PT), 10 mM; ethyl 
4-phenylbutyrate (PB), 5 mM; diphenyl ether (DP), 10 mM; zoxazolamine (ZX), 5 mM; 
propranolol (PR), 4 mM; chlorzoxazone (CH), 5 mM; tolbutamide (TB), 10 mM; 12-p-
nitrophenoxycarboxylic acid (PN), 0.25 mM. The reaction was initiated by the addition 
of NADPH or hydrogen peroxide stock solution (final concentration of 500 µM NADPH 
or 2 mM hydrogen peroxide) and mixed briefly. After two hours at room temperature, 
reactions with substrates 1-10 were quenched with 120 µl of 0.1 M NaOH and 4 M urea. 
Thirty-six µl of 0.6% (w/v) 4-aminoantipyrine (4-AAP) was then added. The 96-well 
plate reader was zeroed at 500 nm and 36 µl of 0.6% (w/v) potassium persulfate was 
added. After 20 min, the absorbance at 500 nm was read [28]. Reactions on PN were 
monitored directly at 410 nm by the absorption of accumulated 4-nitrophenol. All 
experiments were performed in triplicate, and the absorption data were averaged.  
 
1.6.4 Data Analysis 
The background absorbance (BG) was subtracted from the raw data. BG reactions 
contained buffer, cofactor and substrate in the absence of protein sample and were done 
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in triplicates. All absorbance measurements were done once on three separate samples 
(triplicate sampling). Data points with a SD/average ! 20% that did not lie within the 
average ± 1.1*SD were eliminated. 1.1*SD was chosen so that for each substrate at least 
85% of the points were retained. This never resulted in the elimination of more than one 
point from each triplicate set of measurements. All points with an average absorbance     
< BG were set to zero, because they are assumed to belong to inactive proteins. The 
absorbance matrix thus obtained for all 68 proteins on all 11 substrates is displayed in 
Supplemental Table 1.S2. The SD/average matrix is displayed in Supplemental Table 
1.S3. SD/average was calculated ignoring values for inactive enzymes.  
 
1.6.5 Cluster Analysis 
K-means clustering is a partitioning method that divides a set of observations into k 
mutually exclusive clusters. K-means treats each data point as an object having a location 
in m-dimensional space (m=11 in this analysis) [30]. It then finds a partition such that 
members of the same cluster are as close as possible to each other and as far as possible 
to members of other clusters. For this reason, a measure of the meaningfulness of a 
partition is given by the silhouette value ( ) ( )











, where a(i) is the 
average distance of point i to all other points in its cluster and b (i) is the average distance 
of point i to all points in the closest cluster. It is evident that 
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1.8 Supplementary Material 
Table 1.S1: Pair-wise correlations of normalized activities for monooxygenases (R1, R2, 
R3) and peroxygenases (R0) of fourteen chimeras and the A1 and A2 parents. R2 values 
are reported. Bold and underlined=0.7-1.0; Underlined=0.4-0.7; Regular=0.0-0.4. 
 
Heme sequence R0/R1 R0/R2 R0/R3 R1/R2 R1/R3 R2/R3 
11111111 0.49 0.00 0.53 0.21 0.66 0.11 
22222222 0.70 0.53 0.49 0.75 0.83 0.66 
11113311 0.61 0.65 0.49 0.90 0.59 0.78 
12112333 0.11 0.04 0.00 0.91 0.11 0.10 
21113312 0.14 0.01 0.00 0.73 0.76 0.77 
21313111 0.24 0.19 0.05 0.84 0.15 0.39 
21313311 0.25 0.28 0.00 0.41 0.01 0.34 
21333233 0.90 0.64 0.87 0.72 0.95 0.66 
22132231 0.80 0.85 0.56 0.98 0.64 0.60 
22213132 0.46 0.08 0.37 0.11 0.01 0.54 
22312333 0.01 0.02 0.00 0.69 0.69 0.25 
22313233 0.17 0.01 0.08 0.02 0.85 0.07 
23132233 0.96 0.89 0.97 0.90 0.99 0.90 
32312231 0.14 0.06 0.02 0.07 0.04 0.21 
32312333 0.33 0.41 0.02 0.97 0.40 0.33 




Table 1.S2: Average activity in absorbance units for each substrate-construct pair 



























































































11111111-R0 0.105 0.000 0.000 0.000 0.013 0.027 0.000 0.011 0.013 0.011 0.178
11111111-R1 0.152 0.115 0.136 0.053 0.202 0.177 0.055 0.037 0.032 0.033 0.302
11111111-R2 0.484 0.179 0.157 0.118 0.200 0.114 0.146 0.029 0.026 0.029 0.114
11111111-R3 0.048 0.000 0.038 0.000 0.059 0.030 0.054 0.023 0.019 0.022 0.132
22222222-R0 0.054 0.000 0.000 0.000 0.013 0.009 0.000 0.010 0.014 0.011 0.026
22222222-R1 0.042 0.000 0.038 0.000 0.027 0.031 0.020 0.021 0.016 0.020 0.064
22222222-R2 0.039 0.000 0.045 0.000 0.027 0.083 0.022 0.020 0.016 0.018 0.037
22222222-R3 0.065 0.000 0.040 0.000 0.048 0.031 0.055 0.028 0.024 0.024 0.079
33333333-R3 0.049 0.000 0.033 0.000 0.046 0.026 0.056 0.030 0.022 0.024 0.063
11113311-R0 0.463 0.000 0.046 0.000 0.011 0.031 0.000 0.013 0.012 0.009 0.190
11113311-R1 0.448 0.238 0.160 0.072 0.135 0.225 0.061 0.029 0.028 0.027 0.364
11113311-R2 0.329 0.145 0.087 0.000 0.091 0.159 0.051 0.030 0.024 0.024 0.277
11113311-R3 0.118 0.000 0.033 0.000 0.032 0.028 0.047 0.022 0.017 0.019 0.155
12112333-R0 0.544 0.053 0.048 0.000 0.013 0.038 0.000 0.012 0.014 0.013 0.056
12112333-R1 0.513 0.282 0.163 0.091 0.124 0.414 0.038 0.020 0.017 0.019 0.170
12112333-R2 0.511 0.334 0.163 0.116 0.135 0.462 0.063 0.025 0.024 0.025 0.143
12112333-R3 0.129 0.044 0.039 0.000 0.043 0.058 0.080 0.025 0.019 0.022 0.053
21113312-R0 0.522 0.135 0.078 0.000 0.017 0.034 0.000 0.017 0.017 0.013 0.069
21113312-R1 0.269 0.107 0.084 0.000 0.063 0.056 0.046 0.038 0.045 0.034 0.065
21113312-R2 0.213 0.085 0.073 0.046 0.066 0.047 0.055 0.033 0.038 0.031 0.050
21113312-R3 0.179 0.063 0.058 0.000 0.049 0.034 0.075 0.034 0.037 0.033 0.031
21313111-R0 0.731 0.105 0.073 0.000 0.016 0.058 0.000 0.018 0.012 0.013 0.000
21313111-R1 0.617 0.313 0.173 0.167 0.089 0.370 0.044 0.024 0.024 0.024 0.033
21313111-R2 0.560 0.282 0.139 0.152 0.102 0.332 0.079 0.029 0.027 0.028 0.000
21313111-R3 0.767 0.256 0.258 0.207 0.260 0.518 0.137 0.102 0.089 0.076 0.000
21313311-R0 0.365 0.000 0.046 0.000 0.009 0.038 0.000 0.012 0.011 0.012 0.000
21313311-R1 0.343 0.082 0.109 0.061 0.089 0.202 0.017 0.019 0.015 0.019 0.000
21313311-R2 0.306 0.074 0.092 0.000 0.086 0.149 0.050 0.030 0.029 0.029 0.000
21313311-R3 0.190 0.109 0.098 0.097 0.115 0.150 0.136 0.072 0.071 0.060 0.000
21333233-R0 0.113 0.000 0.036 0.000 0.020 0.016 0.023 0.025 0.020 0.020 0.000
21333233-R1 0.046 0.000 0.035 0.000 0.029 0.026 0.022 0.024 0.019 0.022 0.000
21333233-R2 0.180 0.104 0.119 0.000 0.070 0.090 0.039 0.036 0.034 0.031 0.062
21333233-R3 0.057 0.000 0.035 0.000 0.036 0.028 0.040 0.026 0.025 0.024 0.000
22132231-R0 0.034 0.000 0.000 0.000 0.009 0.006 0.000 0.005 0.008 0.007 0.000
22132231-R1 0.025 0.000 0.024 0.000 0.023 0.018 0.000 0.018 0.014 0.018 0.000
22132231-R2 0.045 0.000 0.035 0.000 0.026 0.033 0.000 0.018 0.016 0.020 0.000
22132231-R3 0.022 0.000 0.000 0.000 0.016 0.015 0.025 0.014 0.012 0.015 0.000
22213132-R0 0.269 0.051 0.061 0.000 0.010 0.017 0.020 0.010 0.019 0.013 0.000
22213132-R1 0.584 0.217 0.238 0.076 0.081 0.172 0.068 0.031 0.040 0.030 0.133
22213132-R2 0.377 0.289 0.253 0.169 0.153 0.206 0.152 0.122 0.130 0.126 0.000
22213132-R3 0.172 0.070 0.077 0.000 0.038 0.043 0.051 0.026 0.025 0.024 0.015
22312333-R0 0.103 0.000 0.024 0.000 0.008 0.017 0.000 0.009 0.006 0.009 0.000
22312333-R1 0.080 0.000 0.044 0.000 0.058 0.132 0.082 0.015 0.015 0.018 0.000
22312333-R2 0.172 0.067 0.084 0.049 0.121 0.356 0.117 0.019 0.012 0.017 0.000
22312333-R3 0.034 0.000 0.000 0.000 0.022 0.019 0.093 0.012 0.011 0.015 0.000
22313233-R0 0.185 0.000 0.050 0.000 0.011 0.029 0.000 0.008 0.009 0.010 0.000
22313233-R1 0.064 0.000 0.036 0.000 0.033 0.044 0.023 0.021 0.018 0.021 0.000
22313233-R2 0.260 0.204 0.150 0.137 0.089 0.415 0.049 0.022 0.016 0.019 0.000
22313233-R3 0.077 0.000 0.041 0.000 0.034 0.031 0.053 0.026 0.020 0.023 0.000
23132233-R0 0.024 0.000 0.000 0.000 0.019 0.019 0.022 0.025 0.021 0.021 0.000
23132233-R1 0.044 0.000 0.043 0.000 0.051 0.037 0.035 0.042 0.039 0.036 0.000
23132233-R2 0.049 0.000 0.055 0.046 0.054 0.044 0.043 0.043 0.041 0.038 0.000
23132233-R3 0.030 0.000 0.031 0.000 0.034 0.024 0.025 0.031 0.026 0.028 0.000
32312231-R0 0.354 0.065 0.085 0.000 0.016 0.067 0.000 0.015 0.013 0.018 0.000
32312231-R1 0.067 0.053 0.055 0.000 0.051 0.156 0.063 0.021 0.016 0.021 0.139
32312231-R2 0.204 0.245 0.277 0.154 0.090 0.448 0.063 0.019 0.016 0.020 0.048
32312231-R3 0.064 0.000 0.035 0.000 0.025 0.024 0.044 0.018 0.015 0.018 0.000
32312333-R0 1.101 0.338 0.236 0.076 0.025 0.297 0.067 0.019 0.019 0.019 0.000
32312333-R1 1.030 0.860 0.803 0.320 0.167 0.664 0.233 0.022 0.048 0.023 0.034
32312333-R2 0.907 0.712 0.653 0.246 0.133 0.538 0.174 0.018 0.023 0.022 0.044
32312333-R3 0.212 0.189 0.264 0.178 0.066 0.561 0.145 0.023 0.023 0.023 0.000
32313233-R0 0.796 0.383 0.276 0.095 0.036 0.389 0.121 0.009 0.023 0.023 0.000
32313233-R1 0.249 0.471 0.476 0.280 0.163 0.742 0.261 0.044 0.048 0.039 0.018
32313233-R2 0.535 0.566 0.454 0.197 0.153 0.485 0.229 0.029 0.037 0.029 0.017




Table 1.S3: Standard deviations/ average of absorbance for each substrate-construct pair. 


























































































11111111-R0 0.091 0.233 0.735 0.162 0.148 0.098 0.052
11111111-R1 0.093 0.183 0.058 0.128 0.033 0.118 0.364 0.054 0.128 0.106 0.076
11111111-R2 0.039 0.020 0.118 0.135 0.041 0.030 0.112 0.113 0.120 0.067 0.159
11111111-R3 0.054 0.031 0.029 0.066 0.189 0.092 0.082 0.118 0.083
22222222-R0 0.089 0.156 0.264 0.261 0.005 0.159 0.125
22222222-R1 0.128 0.074 0.077 0.119 0.255 0.076 0.144 0.144 0.040
22222222-R2 0.071 0.054 0.113 0.081 0.251 0.085 0.108 0.099 0.011
22222222-R3 0.053 0.111 0.084 0.070 0.058 0.155 0.123 0.086 0.096
33333333-R3 0.134 0.126 0.017 0.094 0.082 0.110 0.155 0.088 0.068
11113311-R0 0.092 0.097 0.086 0.370 0.117 0.083 0.000 0.058
11113311-R1 0.045 0.158 0.124 0.092 0.159 0.032 0.622 0.084 0.127 0.079 0.007
11113311-R2 0.046 0.018 0.113 0.035 0.079 0.177 0.130 0.102 0.038 0.012
11113311-R3 0.103 0.093 0.033 0.065 0.110 0.110 0.176 0.022 0.102
12112333-R0 0.012 0.046 0.045 0.159 0.034 0.193 0.114 0.067 0.073
12112333-R1 0.092 0.014 0.114 0.107 0.029 0.104 0.065 0.177 0.137 0.069 0.075
12112333-R2 0.054 0.118 0.094 0.021 0.024 0.081 0.115 0.160 0.019 0.073 0.129
12112333-R3 0.039 0.016 0.057 0.020 0.035 0.064 0.082 0.066 0.115 0.133
21113312-R0 0.129 0.076 0.126 0.074 0.176 0.156 0.053 0.156 0.118
21113312-R1 0.065 0.049 0.060 0.045 0.046 0.075 0.156 0.051 0.058 0.250
21113312-R2 0.024 0.190 0.114 0.150 0.064 0.182 0.183 0.182 0.088 0.051 0.379
21113312-R3 0.094 0.147 0.087 0.051 0.044 0.005 0.350 0.121 0.110 0.080
21313111-R0 0.078 0.177 0.142 0.038 0.092 0.138 0.167 0.107
21313111-R1 0.116 0.046 0.019 0.088 0.055 0.032 0.239 0.135 0.107 0.083 0.095
21313111-R2 0.012 0.084 0.076 0.039 0.037 0.069 0.424 0.083 0.106 0.088
21313111-R3 0.038 0.200 0.092 0.034 0.034 0.107 0.195 0.035 0.145 0.127
21313311-R0 0.065 0.143 0.162 0.078 0.041 0.168 0.105
21313311-R1 0.026 0.051 0.166 0.178 0.086 0.024 0.448 0.029 0.097 0.072
21313311-R2 0.137 0.141 0.169 0.018 0.049 0.020 0.183 0.084 0.049
21313311-R3 0.012 0.053 0.038 0.075 0.010 0.111 0.131 0.148 0.091 0.040
21333233-R0 0.062 0.242 0.110 0.188 0.377 0.159 0.133 0.128
21333233-R1 0.095 0.049 0.038 0.192 0.189 0.085 0.074 0.120
21333233-R2 0.036 0.183 0.135 0.016 0.044 0.026 0.119 0.117 0.062 0.105
21333233-R3 0.043 0.044 0.044 0.182 0.067 0.043 0.082 0.041
22132231-R0 0.002 0.180 0.398 0.677 0.060 0.189
22132231-R1 0.052 0.041 0.051 0.077 0.183 0.166 0.110
22132231-R2 0.063 0.067 0.019 0.092 0.063 0.148 0.073
22132231-R3 0.080 0.061 0.014 0.137 0.142 0.160 0.044
22213132-R0 0.153 0.128 0.058 0.081 0.147 0.156 0.166 0.073 0.137
22213132-R1 0.077 0.118 0.104 0.053 0.066 0.058 0.339 0.098 0.147 0.030 0.048
22213132-R2 0.065 0.091 0.059 0.075 0.050 0.039 0.070 0.124 0.120 0.005
22213132-R3 0.097 0.061 0.116 0.061 0.052 0.119 0.144 0.111 0.114 0.000
22312333-R0 0.023 0.173 0.181 0.387 0.151 0.132 0.170
22312333-R1 0.103 0.110 0.046 0.068 0.266 0.098 0.085 0.076
22312333-R2 0.060 0.191 0.108 0.050 0.047 0.059 0.042 0.160 0.091 0.016
22312333-R3 0.101 0.077 0.127 0.153 0.121 0.264 0.038
22313233-R0 0.100 0.158 0.080 0.134 0.334 0.246 0.127
22313233-R1 0.055 0.023 0.158 0.034 0.154 0.101 0.079 0.104
22313233-R2 0.076 0.245 0.144 0.062 0.079 0.019 0.118 0.006 0.134 0.106
22313233-R3 0.028 0.005 0.036 0.141 0.155 0.040 0.081 0.104
23132233-R0 0.056 0.013 0.095 0.058 0.092 0.182 0.086
23132233-R1 0.050 0.109 0.045 0.050 0.060 0.012 0.116 0.078
23132233-R2 0.042 0.009 0.178 0.076 0.067 0.078 0.122 0.091 0.118
23132233-R3 0.061 0.052 0.028 0.047 0.146 0.053 0.089 0.098
32312231-R0 0.119 0.119 0.019 0.085 0.034 0.167 0.105 0.177
32312231-R1 0.114 0.046 0.133 0.108 0.074 0.531 0.050 0.102 0.064 0.190
32312231-R2 0.088 0.061 0.062 0.146 0.107 0.058 0.174 0.096 0.191 0.088 0.085
32312231-R3 0.036 0.014 0.031 0.118 0.054 0.055 0.117 0.051
32312333-R0 0.081 0.074 0.089 0.034 0.071 0.015 0.056 0.137 0.077 0.125
32312333-R1 0.068 0.111 0.045 0.020 0.056 0.113 0.014 0.052 0.102 0.042 0.457
32312333-R2 0.051 0.107 0.035 0.019 0.049 0.097 0.150 0.173 0.023 0.068 0.139
32312333-R3 0.107 0.070 0.079 0.133 0.030 0.075 0.095 0.050 0.078 0.069
32313233-R0 0.090 0.149 0.049 0.120 0.031 0.140 0.050 1.863 0.074 0.067
32313233-R1 0.143 0.105 0.036 0.011 0.063 0.089 0.184 0.147 0.078 0.044 0.062
32313233-R2 0.064 0.053 0.033 0.020 0.083 0.113 0.102 0.122 0.072 0.035 0.346




Table 1.S4: Summary of error statistics for collected absorbance data sorted by 
substrates. The percentage of the standard deviation divided by the average value and the 
percentage of data points retained for the analysis are measures of data quality. For each 
substrate, 65 data points were collected. The Triplicates/Duplicates column indicates how 










2-phenoxyethanol (PE) 7.1 99 63/2 
ethoxybenzene (EB) 10.2 87 39/26 
ethyl phenoxyacetate (PA) 8.5 95 56/9 
3-phenoxytoluene (PT) 8.0 94 53/12 
ethyl 4-phenylbutyrate (PB) 6.7 100 65/0 
diphenyl ether (DP) 10.9 95 56/9 
zoxazolamine (ZX) 16.0 87 40/25 
propranolol (PR) 15.6 90 45/20 
chlorzoxazone (CH) 11.2 99 63/2 
tolbutamide (TB) 8.5 99 63/2 




Table 1.S5: Summary of most active chimeric proteins for each substrate. Pair-wise 
correlation matrix of the activities on all substrates. ). R2 values are reported. Bold and 
underlined=0.7-1.0; Underlined=0.4-0.7; Regular=0.0-0.4 
 
Protein  PE EB PA PT PB DP ZX PR CH TB PN 
32312231-R0 PE N.A. 0.61 0.48 0.37 0.18 0.35 0.15 0.01 0.05 0.02 0.01 
32312231-R1 EB  N.A. 0.92 0.80 0.41 0.73 0.56 0.04 0.13 0.06 0.00 
32312231-R1 PA   N.A. 0.81 0.39 0.71 0.62 0.04 0.14 0.06 0.00 
32312231-R1 PT    N.A. 0.56 0.85 0.66 0.14 0.24 0.16 0.00 
21313111-R3 PB     N.A. 0.49 0.49 0.36 0.37 0.33 0.08 
32313233-R1 DP      N.A. 0.58 0.05 0.10 0.06 0.00 
32313233-R1 ZX       N.A. 0.18 0.29 0.21 0.00 
22213132-R2 PR        N.A. 0.91 0.95 0.00 
22213132-R2 CH          N.A. 0.94 0.00 
22213132-R2 TB          N.A. 0.00 











Figure 1.S1: Examples of the correlation of absorbances values measured within 
substrate Group A and Group B. Panel A shows the correlation between diphenyl ether 
(DP) and ethyl phenoxyacetate (PA) with a R2=0.71. Panel B shows the correlation 
















































































































































































































Figure 1.S2: Substrate-activity profiles of all chimeras. The columns are color coded as 











Native enzymes have been highly optimized by natural evolution to perform their 
biological function. For this reason, improving the native activities of wild-type enzymes 
is challenging and often unsuccessful. Yet there are scientific and industrial applications 
that would benefit from an understanding of how to do this. Here, I propose that proteins 
with mutational neighborhoods that have never been searched by evolutionary processes 
are more evolvable than native proteins of equal fitness. I propose that homologous 
recombination can be used to design proteins with unexplored mutational neighborhoods 
because it affords the simultaneous incorporation of numerous neutral mutations. I 
validate this hypothesis in the context of lattice proteins, which are highly simplified 
models of a protein on a two-dimensional lattice. The underlying assumption of my 
hypothesis is that the constraints that prevent improving the activities of native enzymes 
are evolutionary rather than biochemical or biophysical (i.e., native enzymes are locally 
rather than globally optimized).  
 
2.2 Introduction 
Native enzymes are the products of millions of years of evolution. Evolutionary pressure 
fine-tuned their amino acid sequence to optimize biological function. This may translate 
to maximizing catalytic activity, resistance to high temperatures or extremely acidic 
environments, regioselectivity, stereospecificity, and more. As a consequence, 
experimental efforts to further improve phenotypic properties that underwent selection 
during natural evolution, such as the thermostability of an enzyme from a thermophilic 
organism or the catalytic activity of an enzyme on its native substrate, are often very 
laborious and yield small improvements. Yet, overcoming these difficulties could 
potentially have a tremendous impact on certain scientific applications. As an example, 
cellulases, a class of enzymes the catalyze the hydrolysis of cellulose to sugar, could play 
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a significant role in the development of an environmentally friendly alternative to 
gasoline and the attenuation of the energy crisis, but their specific activity is too low 
[51,52]. Protein engineers have devoted much effort to improving the activities of these 
enzymes without significant success.  
In general we do not know whether the constraints that prevent improving the 
native activities of wild-type enzymes are physical or evolutionary. In some cases natural 
evolution has driven native enzymes to be so efficient that they are binding substrate and 
releasing product as fast as diffusion allows. These enzymes are globally optimized and 
cannot be engineered to perform better. In most cases, however, there is no evidence of 
physical limitations constraining the activities of native enzymes. In fact it is not unlikely 
that many natural enzymes are only locally optimized (i.e., none of the possible single 
mutational steps lead to an increase in fitness despite the existence of better enzymes) and 
need many amino acid substitutions to escape the local optima.  
In nature recombination may have aided proteins escape local maxima of the 
fitness landscape (fitness as a function of sequence) by introducing many homologous 
mutations to which proteins are highly tolerant. With data from chimeric and randomly 
mutated ß-lactamases, Drummond et al. [1] showed that recombination is much more 
conservative than random mutation, leading to a probability of folding and retaining 
function that is many orders of magnitude greater at the highest mutation levels. In fact, 
Heinzelman et al. recently designed a chimeric library of cellulases containing members 
with wild-type levels of cellulolytic activity and over 50 mutations relative to their 
closest parent [53]. Before them, others were able to achieve similar results with ß-
lactamases and P450s [3,5]. The dozens of neutral mutations afforded by recombination 
may allow protein engineers to bypass the local maxima of native enzymes. 
I propose that chimeras, on average, are more evolvable than their parents because 
evolutionary processes have not searched their mutational neighborhood. This argument 
trivially holds true for chimeras that are less fit than their parents, but also applies to 
chimeras that are as fit as their parents. Here, an enzyme is evolvable in the sense that 
beneficial mutations can be found in its mutational neighborhood. The basic intuition is 
that the probability of finding beneficial mutations is higher in regions of sequence space 
that have not already been searched by evolution than in regions that have. Note that this 
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argument does not require that native enzymes be strictly locally maximized. Rather, it 
only requires that their mutational neighborhood be explored by evolution. The 
underlying assumption of this argument is that native enzymes are not globally 
optimized.  
Since the building blocks of chimeras are derived from native enzymes, it is 
unclear whether their mutational neighborhood is effectively unexplored. A mutation is 
effectively unexplored when the contribution to fitness that it makes in a chimeric 
background is different from the contribution it makes in a parental background. This 
occurs when the contribution depends on the amino acid identities of other residues. If it 
depends on one other residue, the pair forms a second order interaction. If it depends on 
two other residues the triplet forms a third order interaction and so on. As suggested by 
Figure 2.1A, mutations must be recruited into locally non-native environments to make 
different contributions to fitness in a chimera versus a parent, unless they interact with 
distal residues.  
The crossovers of recombination can disrupt native interactions and form new 
non-native interactions. When a residue interacts with a single other residue, the 
formation of a new interaction does not grant access to effectively unexplored mutations. 
This is because all pair-wise combinations of amino acids that are accessible to the 
chimera are also accessible to one of their parents (Figure 2.1B). However, when a 
mutation occurs in a network of three or more interacting residues then, provided the 
network was disrupted by the crossovers of recombination, chimeras can gain access to 
combinations of amino acids that are not accessible to their parents (Figure 2.1B). In 
order for chimeras to be more evolvable than their native parents, there must exist 
mutations that are beneficial in the background of the former but not in that of the latter. 
This can occur only when a mutation is recruited into a network of three or more 
interacting residues that was disrupted by the crossovers of recombination. Thus, the 
neighborhood of chimeric enzymes includes effectively unexplored mutations when 1) 
third and higher order interactions contribute to fitness, and 2) the crossovers of 





Figure 2.1: A. Effect of mutations in different chimeric lattice protein backgrounds. The 
red and blue segments represent fragments derived from different native proteins and the 
magenta circle represents a point mutation. When mutations are recruited into locally 
native environments (left) they interact with the same residues and make the same 
contributions to fitness as they would in a parental background unless they also interact 
with distal residues. Instead, when they are recruited into less native environments (right) 
they are less likely to make the same contribution to fitness in native and chimeric 
backgrounds. B. Chimeras can access combinations of residues not accessible to their 
parents only when third or higher order interactions are disrupted by crossovers. Red and 
blue circles represent residues from different parents and dotted lines represent 
interactions. Magenta circles represent point mutations. When a mutation occurs in the 
context of a pair-wise interaction that was disrupted by a crossover, it leads to a 
combination of amino acids that was accessible by a single mutation in the native 
background. Instead, when three or more residues are interacting, mutations lead to 




Here, I use the lattice protein framework to investigate the relationship between the 
order of the interactions contributing to fitness and the evolvability of chimeric lattice 
proteins relative to native ones. Lattice proteins are highly simplified models of a protein 
consisting of a chain of 20 monomers on a two-dimensional lattice. Lattice proteins have 
been widely used to address questions of general principle related to protein folding, 
structure, and evolution. For example, lattice proteins have been used to propose 
statistical explanations to the marginal stability of real proteins [54] and the apparent 
anti-correlation between stability and activity [55]. In some cases, the results from lattice 
protein simulations have been validated by observations made on real proteins and by 
direct experimentation. For example, lattice protein simulations predict that sequences 
enriched in consensus amino acids are highly stable and robust to mutations [56,57]. 
Consensus mutations have been widely used to stabilize proteins [58-61] and Bloom and 
co-workers showed that stable enzymes are more robust to mutations [62]. A 
comprehensive review on lattice proteins can be found in [63]. 
I show that lattice proteins whose mutational neighborhoods have not been 
searched by evolutionary processes are more evolvable than native lattice proteins having 
equal fitness. I show that the mutational neighborhood of chimeric lattice proteins is 
effectively unexplored only when high order interactions contribute to fitness and are 
broken by the crossovers of recombination. Here, the evolvability of a lattice protein is 
evaluated according to three measures: 1) the number of improved single-mutant 
neighbors, 2) the greatest improvement in fitness among the improved neighbors, and 3) 
the fitness attained after a steepest ascent walk. A steepest ascent walk is one in which 
after each step the fitnesses of all the single-mutant neighbors are enumerated and the 
walk moves to the sequence bearing the greatest improvement in fitness until a local 
maximum is reached. To a first approximation, directed evolution is a steepest ascent 
walk.  
Proteins with unexplored mutational neighborhoods can be expected to have a 
greater number of improved single-mutant neighbors because the probability that a 
mutation is beneficial given that it has never been tested by evolution (as is the case for 
mutations occurring in enzymes with unexplored mutational neighborhood) is higher than 
the probability that a mutation is beneficial given that it has been tested but not selected 
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by evolution (as is the case for mutations occurring in native proteins). Therefore, on 
average, I expect proteins with unexplored mutational neighborhoods to have access to a 
greater number of beneficial mutations than native proteins having equal fitness (first 
measure of evolvability). Likewise, strongly beneficial mutations are unlikely to be found 
in the neighborhood of native enzymes because if they existed evolution would have 
selected them. Thus, I expect proteins with unexplored mutational neighborhoods to have 
access to more strongly beneficial mutations than native proteins having equal fitness 
(second measure of evolvability). Finally, after each step of a steepest ascent walk, I 
expect chimeras to continue encountering more and better beneficial mutations than 
native proteins (for the same reasons supporting the first two measures of evolvability) 
and thus attain a higher fitness at the end of the walk (third measure of evolvability). This 




2.3.1 Lattice Proteins 
The lattice proteins [55,62-66] used in the simulations are highly simplified models of a 
protein consisting of a chain of 20 monomers on a two-dimensional lattice that can 
occupy any one of 41,889,578 possible compact or non-compact conformations. The 
monomers can be of 20 types corresponding to the 20 amino acids. Each monomer on the 
lattice has four nearest-neighbor sites, of which as many as two can be occupied by 
nonbonded neighboring residues (three in the case of terminal residues). The energy of a 
target conformation
 
CT is given by, 
 






" #$ Pi,Pj( ) ,  
where 
 
Cij CT( )  is one if residues i and j are nonbonded nearest neighbors in conformation 
 
C  and zero otherwise, and 
 




Pj  based on a widely used statistical analysis of real proteins by Miyazawa and Jernigan 
[67]. The free energy of folding of a lattice protein is related to the difference between 
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CT  is the target conformation and 
 
Q T( ) is the partition function: 
 









All simulations were performed at a reduced temperature of 
 
T =1.0. Proteins are 
defined to be folded if their free energy of folding is less than or equal to zero.  
For those proteins that stably fold activity is modeled as the binding energy (BE) 
of a small rigid peptide ligand to the active site of a folded lattice protein. The basic idea 
is that if a protein folds with at least the minimal required stability, then evolution selects 
for a protein’s function and is indifferent to the actual stability. This model of lattice 
protein folding and function has been used by others to investigate the evolvability of 
new functions in stable proteins [62] and to investigate the correlation between activity 
and stability [55]. The models of ligand binding in the present study are different from 
those reported previously because they include high order contributions (up to fifth 
order).  
In the simplest model, the BE (BE and activity are used interchangeably; fitness 
refers to the BE and/or the 
 
"Gf ) is the summation of adjacent protein-ligand residue 
interactions as shown by the red dotted lines in Figure 2.2 (model 1). In this model, 
protein residues make independent contributions to the BE (first order), and higher order 
contributions to fitness are introduced solely by the requirement that 
 
"Gf # 0  in order for 
the lattice protein to bind the ligand. In the remaining models, the BE is the summation of 
first order protein-ligand interactions and second (model 2), third (model 3), or fifth 
(model 5) order intra-protein interactions.  
In real proteins, residues have been observed to make both first and high order 
contributions to the activity of enzymes. In homologous enzymes, for example, residues 
that are directly involved in a specific function are often conserved despite the great 
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sequence diversity that can be observed in their vicinity. Their contributions are thus 
largely independent of sequence and largely first order. The conserved cysteine that is 
responsible for the proper positioning of the heme in the P450 family represents a good 
example of this. At the same time, high order contributions to fitness have frequently 
been reported, in particular when catalytic activity is being studied rather than stability 
[68-71]. Thus, my models include both first and high order contributions to the BE. The 
BE function of models 2, 3, and 5 is composed of a first order term and a high order term. 
Since each first order protein-ligand interaction is, on average, equal in magnitude to 
each high order interaction (see below), the relative number of first and high order 
interactions indicates the relative contribution that each of these terms makes to the BE. 
Thus, the contributions to the BE from high order interactions are 33%, 33%, and 50% in 
models 2, 3, and 5 respectively. Model 5 is composed of six first order interactions and 
six fifth order interactions involving most of the 20 residues of the lattice protein. The 
frequency of high order interactions in this model is very high and not intended to depict 
realistic models of ligand binding. Instead, this model was included to elucidate a 
qualitative trend. 
In the second order model, interactions were assigned manually, and protein-
protein interactions involve only active site residues. In the third order model, all adjacent 
protein-ligand residues are interacting, and third order interactions involve one active site 
residue and two residues randomly chosen in silico with a probability inversely 
proportional to their distance from the active site residue. Likewise, in the fifth order 
model, all adjacent protein-ligand residues are interacting and the fifth order interactions 
involve one active site residue and four residues randomly chosen in silico with a 
probability inversely proportional to their distance from the active site residue. There are 
numerous reports of non-active site mutations that alter catalytic activity in real enzymes 
[72-75] and for this reason I included long-range interactions in some of my models. 
All binary interactions (protein-ligand and protein-protein) are those proposed by 
Miyazawa and Jernigan [67] (Table 5). Since Miyazawa and Jernigan limited their 
analysis to pair-wise interaction energies, the third and fifth order interactions were 
selected randomly from the same distribution [67] (Table 5). This was done to ensure 
that, on average, the contribution of each third and fifth order interaction was equal in 
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magnitude to the contribution of a single pair-wise interaction between the lattice-protein 
and the ligand. This is important to ensure that the high order contributions do not 
overwhelm the first order protein-ligand contributions and viceversa. Besides the relative 
magnitudes of the first and high order interaction energies, I do not expect the exact 
nature of their distributions to affect the qualitative features of my results.  
Unlike the pair-wise interactions, the third and fifth order interactions are position 
dependent (i.e., the interaction Met-Arg-Tyr is different from Arg-Met-Tyr). The 
Miyazawa and Jernigan potentials reflect the average energetic contributions that 
contacting amino acid pairs make to real protein stability and they inherently do not 
depend on position. However, since the third and fifth order interactions involve distal 


























Figure 2.2: Lattice protein models. Black solid line: lattice protein; blue solid line: 
ligand; red dotted lines: first order protein-ligand interactions; and green dotted lines: 
second, third or fifth order intra-protein interactions. Note that in model 1 the BE is a 
purely additive function and the ruggedness of the fitness landscape arises from the 
folding constraint. The BE of models 2, 3, and 5, instead, has second, third, and fifth 
order contributions. Model 5 is composed of six first order and six fifth order 
interactions. Each fifth order interaction is shown separately so they can be visualized 
more clearly. In every model, the BE energy is equal to the summation of all first and 
high order interactions. 
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2.3.2 Evolutionary Simulations 
A random search was performed to identify a set of 1,143 sequences, 
 
Sran , that stably fold 
into the native structure shown in Figure 2.2. To create a set of “native” sequences, 
 
Snat , 
each of these 1,143 random sequences was evolved seven independent times for 1,000 
generations for improved BE with the ligands shown in Figure 2.2 (FGLLGD for model 
1, AMHYRTFGLLGDTE for model 2, and LGNVAELLK for model 3 and 5) (a total of 
1,143
 
"  7 = 8,001 evolutionary runs for each model). The qualitative features of my 
results were not found to depend on the sequence of ligands (data not shown). For each 
evolutionary run, the starting population is composed of ten identical lattice protein 
sequences equal to one of the random sequences. At each generation ten offspring are 
produced.  These offspring are identical copies of existing members of the population, 
with the probability of a copy being from a member of the population being proportional 
to the quantity, 
 
e"BE , associated with that member of the population.  These new 
sequences then replace the existing sequences in the population (note that the population 
size is kept constant).  All members of the population are then mutated with a per site 
mutation rate of 0.005. The final BE is that of the most abundant lattice protein sequence 
in the population after 1,000 generations. Native real enzymes are probably not strictly 
locally maximized. Rather they may have access to a few mildly beneficial mutations. 
Like wise, in the present work, native lattice proteins are not constrained to local 
maxima. This is achieved by carrying out evolutionary simulations for a fixed number of 
generations. As a result, some lattice proteins will be strictly locally maximized and 
many will not. 
2.3.3 Creation of Chimeric Lattice Proteins 
The sets of native sequences were used to create hundreds of chimeric families for each 
of the four models. One hundred families containing 50 unique chimeras were made for 
model 1, 283 families containing 50 unique chimeras were made for model 2, and 313 
families containing 25 unique chimeras were made for model 3 and 5. Each chimeric 
family consists of a collection of unique chimeras derived from the same three parents. 
The parents of each family are selected randomly from the seven possible native 
sequences that evolved from the same random sequence. This was done because 
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homologous enzymes in nature share a common ancestor. In fact, the average difference 
in sequence between parents of the same family is lower than what one would expect if 
the two sequences were drawn at random. Chimeras were accepted into their family 
provided they differed by at least 
 
nmin  residues from their closest parent. Each chimera 
was constructed by randomly selecting the positions and the number of crossovers 
(between 1 and 
 
cmax ) and then randomly selecting the parents that went into the segments 
defined by the crossovers. The parameters used to create chimeras for model 1, 2, 3, and 
5, respectively, are: 
 
nmin =10  and 
 
cmax = 7 , 
 
nmin =11 and 
 
cmax = 7 , 
 





nmin = 5  and 
 
cmax =1. Higher values of 
 
nmin  and 
 
cmax  were used in the lower order 
models to increase the probability that crossovers diversify the residues contributing to 
the BE. This is because in model 1 only four residues contribute to the BE and in model 2 
all the intra-protein pair-wise interactions are adjacent in sequence (and thus less likely to 
be separated by crossovers than interactions that are not adjacent in sequence). 
2.4 Results 
2.4.1 Proof of Principle: Lattice Proteins with Unexplored Mutational 
Neighborhoods are more Evolvable than their Native Counterparts 
To obtain a proof of principle that lattice proteins whose mutational neighborhood has 
not been searched by evolutionary processes can be more evolvable than native lattice 
proteins of equal fitness, the evolvabilities of the random proteins in 
 
Sran  were compared 
to those of the native proteins in 
 
Snat  having equal fitness. The native proteins are the 
products of 1,000 generations of evolution. Their mutational neighborhood has thus been 
searched by evolutionary processes. On the other hand, the random sequences were 
generated randomly and their mutational neighborhood is entirely unexplored. Two sets, 
 
sran  and 
 
snat , were extracted from 
 
Sran  and 
 
Snat , respectively, such that 
 
sran  and 
 
snat  have 
indistinguishable distributions of free energies and BEs (please refer to the next section 
for the details on how this is done). It is important to control for the free energy of 
folding because sequences having greater stability can tolerate a greater number of 
destabilizing mutations and are thus more evolvable [62]. It was not possible to generate 
 
sran  and 
 
snat  for models 3 and 5 because the random sequences had considerably worse 
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BEs than the native ones.  This is to be expected for more complex fitness functions 
because it becomes less likely to randomly generate highly fit sequences. In the next 
section, models 3 and 5 will be used to generate chimeric lattice sequences, which, unlike 
random sequences will exhibit BEs comparable to their native parents. The cumulative 
distribution functions (CDF) of the free energies and BEs of 
 
sran  and 
 
snat  are shown to be 
statistically indistinguishable in Supplementary Figure 2.S1 and their average values are 
summarized in Supplementary Table 2.S1. 
 Here, the evolvability of a lattice protein is evaluated according to three measures: 
1) the number of improved single-mutant neighbors, 2) the greatest improvement in BE 
among the improved neighbors, and 3) the BE attained after a steepest ascent walk. A 
steepest ascent walk is one in which after each step the fitness values of the 
 
19 " 20 = 380  
single-mutant neighbors are enumerated and the walk moves to the sequence bearing the 
greatest improvement in BE until a local maximum is reached. The stabilities and BEs of 
all the single-mutant neighbors of the members of 
 
sran  and 
 
snat  (consisting of 380 mutants 
for each sequence) were characterized. The number of neighbors that stably fold and 





snat  to compare their evolvabilities according to the first measure of evolvability. 
Following this calculation, the greatest increment in BE among the neighbors exhibiting 
improvement was determined for each sequence in 
 
sran  and 
 
snat  to compare their 
evolvabilities according to the second measure of evolvability. Finally, each sequence in 
 
sran  and 
 
snat  was subjected to a steepest ascent walk to compare their evolvabilities 
according to the last measure of evolvability. The CDFs of the number of improved 
neighbors, the greatest improvement in BE among the improved neighbors, and the BEs 
attained after a steepest ascent walk of the sequences in 
 
sran  and 
 
snat  are shown for each 




Figure 2.3: CDF of the number of improved neighbors (top), the greatest BE 
improvement among the improved neighbors (center), and the BE attained after a steepest 
ascent walk (bottom) (the black (
 
snat ) and grey (
 
sran ) lines represent the starting BEs 
before the steepest ascent walk and are the same distributions shown in the right panels of 
Supplementary Figure 2.S1). Left panels: model 1 (p = 10-8; p = 10-4; p = 0.03), and right 
panels: model 2 (p = 10-4; p = 0.02, p = 0.03). The p-values here and elsewhere in this 
chapter are based on the two-sample Kolmogorov-Smirnov test [76] and represent the 
probabilities that the CDFs associated with
 
sran  and 
 
snat  would look the way they do if 
they were drawn from identical distributions. Thus, p-values that are close to zero 




Figure 2.3 shows that in both models random lattice proteins are more evolvable 
than native ones of equal fitness according to all three measures of evolvability. Random 
lattice proteins have access to more and better beneficial mutations and can attain lower 
BEs after a steepest ascent walk than native lattice proteins of equal fitness. For each 
steepest ascent walk, the number of improved neighbors after each step of the walk and 
the total number of steps taken were recorded. As anticipated, after each step of the walk 
random proteins continue to encounter a greater number of improved neighbors than 
native proteins and can thus take a greater number of steps before reaching a local 
maximum (data not shown). Presumably, this is because evolution searched the 
mutational neighborhood of the native proteins beyond the one one-mutant neighbors. 
This allows them to walk, on average, to lower BEs than native lattice proteins.  
The results obtained in this section serve as a proof of principle that sequences 
with unexplored mutational neighborhoods can be more evolvable than native sequences 
of equal fitness.  
 
2.4.2 Chimeric Lattice Proteins are more Evolvable than their Native Lattice 
Proteins when their Mutational Neighborhood is Effectively 
Unexplored 
The building blocks of chimeric lattice proteins are derived from native lattice proteins. 
Thus, unlike the random lattice proteins, it is unclear whether their mutational 
neighborhood is effectively unexplored by evolutionary processes. As described in the 
introduction, mutations occurring in chimeric backgrounds are effectively unexplored 
when they occur in a network of three or more interacting residues that are disrupted by 
the crossovers of recombination. To characterize the dependence of the evolvabilities of 
chimeric lattice proteins (relative to those of native lattice proteins) on the order of the 
interactions contributing to the BE, BE models composed of interactions ranging from 
first to fifth order were studied and compared. 
The free energies of folding and the BEs of the chimeric lattice proteins were 
calculated and are shown in Figure 2.4 for the chimeras that fold with 
 
"Gf # 0 . Figure 
2.4 shows that, as the order of the interactions in the four different models increases, the 
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average BE of the chimeras relative to that of their parents worsens. This is consistent 
with experimental observations made on real chimeras that show that, on average, newly 
formed interactions are deleterious to function [77]. Therefore, chimeras will suffer a 
greater loss in fitness when the opportunity to form new interactions is higher.  
 
Figure 2.4: BEs and free energies of folding of the chimeras and native lattice proteins. 
Each blue dot represents a chimera and each red dot represents a native protein. 
 
The chimeras of model 2, 3, and 5 are trivially more evolvable than their parents 
because, on average, they have lower BEs. In order to compare the evolvabilities of 
parental and chimeric lattice proteins having equal fitness, two subsets, 
 
schi  and 
 
snat , were 







respectively, such that 
 
schi  and 
 
snat  have indistinguishable distributions of free energies of 
folding and BEs. This was done in the following way. For each point representing a 
chimera in Figure 2.4, a single point representing a parent from the set of points lying 
within a cutoff radius of that chimera was randomly chosen and added to 
 
snat . The chosen 
parent was then removed from 
 
Snat  to ensure that it would not be selected again for a 
different chimera. This guarantees that 
 
schi  and 
 
snat  have the same size and contain only 
unique sequences. The resulting parents and chimeras in 
 
schi  and 
 
snat  are shown in 
Supplementary Figure 2.S2. The length of the cutoff radius was chosen in such a way that 
the distributions of BEs and free energies of folding associated with 
 
schi  and 
 
snat  were 
statistically indistinguishable according to the two-sample Kolmogorov-Smirnov test 
[76]. The sizes of
 
schi  and 
 
snat  were 144, 473, 223, and 75 for models 1, 2, 3, and 5 
respectively. As long as the distributions of binding and free energies remain 
indistinguishable, the qualitative nature of my results is not affected by variations of the 
cutoff radius. The CDFs of the BEs and free energies of folding associated with 
 
schi  and 
 
snat  are shown to be statistically indistinguishable in Supplementary Figure 2.S3.  
The evolvabilites of the lattice proteins in 
 
schi  and 
 
snat  were determined in the 
same way described in the previous section. The CDFs of the number of improved 
neighbors and the CDFs of the greatest improvement in BE among the improved 
neighbors are shown for each model in Figure 2.5. Their average values are summarized 




Figure 2.5: CDF of the number of improved neighbors (left) and the greatest BE 
improvement (right) among the improved neighbors of sequences in 
 
schi  and 
 
snat . First 
row: model 1 (p = 0.7; p = 0.7); second row: model 2 (p = 0.006; p = 0.006); third row: 
model 3 (p = 10-18; p = 10-26); last row: model 5 (p = 10-23; p = 10-18). 
 
It is immediately apparent from Figure 2.5 that the differences between the 
evolvabilities of chimeric and native lattice proteins increase as the order of the 
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interactions that contribute to the BE increases. In the case of model 1, chimeric and 
native lattice proteins exhibit indistinguishable evolvabilities. This is not surprising 
because residues make independent contributions to the BE. Any mutations that are 
beneficial in the context of a chimera are also beneficial in the context of a native parent. 
Thus, evolution has effectively searched their mutational neighborhood and they cannot 
be more evolvable than native proteins. In contrast, in models 3 and 5, the chimeras are 
significantly more evolvable than native proteins. When a mutation occurs in a network 
of three or more interacting residues then, provided the network is disrupted by the 
crossovers of recombination, chimeras can gain access to combinations of amino acids 
that are not accessible to their parents (Figure 2.1B). Thus, mutations occurring at these 
sites are effectively unexplored by evolution and chimeras can exhibit greater 
evolvability than their native counterparts. In model 2 chimeras are more evolvable than 
the native proteins but the differences are substantially less pronounced. Mutations 
occurring in networks of only two interacting residues lead to combinations of amino 
acids that are already accessible to the parents (Figure 2.1B). Therefore, in order for them 
to make beneficial contributions in the chimeric but not the parental backgrounds, they 
must occur in the context of a non-native interaction (formed by recombination) that is 
deleterious with respect to the native interaction. However, when too many deleterious 
interactions are formed by recombination the chimera will suffer a significant loss in BE. 
Since this study is only concerned with the evolvabilities of chimeras having comparable 
fitnesses as their native counterparts, such a chimera would not be included in 
 
schi . 
Therefore, as verified by the results, chimeras from model 2 are not expected to be 
significantly more evolvable than native proteins. 
Each of the sequences in 
 
schi  and 
 
snat  from models 2, 3, and 5 was subjected to a 
steepest ascent walk to compare their evolvabilities according to the last measure of 
evolvability. This analysis was not carried out on the sequences of model 1 because the 
evolvabilities of the chimeric and native lattice proteins were already shown to be 
indistinguishable based on the first two measures. The CDFs of the BEs attained after the 
steepest ascent walk and the number of steps taken before reaching a local maximum are 









snat  (left panels) (the color scheme is the same as that in Figure 2.3), and CDF of the 
number of steps taken before reaching a local maximum (right panels). Top: model 2 (p = 
0.34; p = 0.44); middle: model 3 (p = 10-12; p = 0.003); bottom: model 5 (p = 10-16; p =  
10-5).  
 
The left panels of Figure 2.6 show that when chimeras and native proteins having 
equal starting BEs and free energies of folding are subjected to a steepest ascent walk, the 
chimeras attain substantially lower BEs than native lattice proteins provided the BE 
model includes high order contributions. Likewise, chimeras, on average, take a greater 
number of steps before attaining a local optimum (right panels) and encounter a greater 
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number of improved neighbors after each step of the walk than native lattice proteins 
(data not shown). Presumably, this is because evolution has searched the mutational 
neighborhood of native enzymes beyond the one-mutant neighbors. Thus, provided the 
model of BE is composed of high order terms, just like random lattice proteins, chimeric 
lattice proteins are more evolvable than their native counterparts according to all three 
measures of evolvability. This is consistent with the hypothesis that chimeras are more 
evolvable than native enzymes because their mutational neighborhood is unexplored by 
evolutionary processes, but that their mutational neighborhood is only effectively 
unexplored when high order interactions contribute to fitness. Since random sequences 
are not composed of native residues, their mutational neighborhood is effectively 
unexplored independently of the order of the interactions contributing to their fitness.  
I have shown that chimeras are more evolvable than their parents when third or 
higher order interactions contribute to the BE. However, as suggested by Figure 2.1B, 
mutations can lead to novel combinations of amino acids only when they occur in a 
network of three or more interacting residues that was disrupted by recombination. 
Crossovers do not necessarily cut though interacting residues. For this reason, the 
chimeras in 
 
schi  of models 3 and 5 that do not have any non-native interactions should not 
exhibit greater evolvability than their native counterparts. To illustrate this, the number of 
non-native interactions was determined for each chimera in 
 
schi . Forty-one out of the 223 
sequences in 
 
schi  of model 3 do not have any non-native third order interactions. The 
evolvabilities of these 41 sequences were compared to those of the native sequences 
according to the usual three measures of evolvabilty. The same comparison was made 
between sequences in 
 
schi  having a single non-native interaction and the native 
sequences. The results are shown in Figure 2.7. As anticipated, the evolvabilities of 
chimeras in model 3 that do not have non-native interactions are indistinguishable from 
those of the native proteins. Instead, chimeras having a single non-native interaction are 
significantly more evolvable than native parents according to all three measures of 
evolvability. This analysis was not possible in the case of model 5 because all the 
chimeras in 
 
schi  have at least one non-native interaction. These results show that the 
crossovers of recombination must break existing high order interactions in order for 
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chimeras to gain access to beneficial mutations that are not beneficial in the context of 
native enzymes.  
In summary, chimeric lattice proteins can be more evolvable than native lattice 
proteins provided, 1) third or higher order interactions contribute to fitness, and 2) the 










Figure 2.7: Comparison of the evolvabilities of the native sequences in 
 
sevo and the 
chimeric ones in 
 
schi  having either zero (left) or one (right) non-native third order 
interaction(s) (this analysis is based on model 3). As usual the sets 
 
schi  and 
 
sevo have 
indistinguishable distributions of free energies and BEs (data not shown). Despite the 
large differences in evolvabilities among the complete sets of sequences in 
 
schi  and 
 
sevo of 
model 3 (p = 10-18, p = 10-26, p = 10-12), the evolvabilities become indistinguishable (p = 
0.38, p = 0.38, p = 0.90) when only chimeric sequences with no broken interactions are 
allowed in 
 
schi . A single non-native interaction is sufficient to grant chimeras greater 




The present work proposes that chimeric proteins with unexplored mutational 
neighborhoods are more evolvable then native ones of equal fitness and validates this 
hypothesis in the context of four different lattice protein fitness landscapes. Here, the 
evolvability of a lattice protein is evaluated according to three measures: 1) the number of 
improved single-mutant neighbors, 2) the greatest improvement in BE among the 
improved neighbors, and 3) the BE attained after a steepest ascent walk. I show that 
chimeric lattice proteins are more evolvable than native lattice proteins when 
contributions to the BE include third or higher order terms and the crossovers of 
recombination disrupt existing native interactions and replace them with new, non-native 
ones. When the contributions to the BE energy include only first or second order terms 
the evolvabilities of the chimeras are indistinguishable from those of the native proteins. 
However, unlike chimeric lattice proteins, random lattice proteins do exhibit significantly 
greater evolvabilities relative to native ones with these low order models. These results 
support the argument that non-native sequences must have an effectively unexplored 
mutational neighborhood to be more evolvable than native ones. Since random sequences 
are not composed of native residues, their mutational neighborhood is effectively 
unexplored independently of the order of the interactions contributing to their fitness.  
 These results have practical relevance when it is desirable to improve the native 
activities of real enzymes and there is evidence that there exist no beneficial mutations in 
their near neighborhood. Enzymes with cellulolytic activity represent a relevant example.  
Efforts to improve their catalytic efficiency on cellulose by directed evolution have not 
lead to significant success. Recently, Heinzelman et al. [53] constructed a chimeric 
library of celluases using structure-guided recombination. Several members of this library 
have over 50 mutations relative to their closest parent and have been shown to exhibit 
wild-type levels of specific activity on cellulose. Provided the parent cellulases are not 
globally optimized, my results suggest that the chimeras may represent a better starting 
point for directed evolution experiments.  
 The purpose of this study was to elucidate a qualitative trend rather than to build 
realistic protein BE models. For this reason, it is important to understand the differences 
between the models of BE used in this work and the functions relating sequence to 
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activity in real proteins. In real proteins, on average, only 5-15% of residues are directly 
involved in binding substrates. In the lattice protein models, 20%, 40%, 60%, and 85% of 
residues make direct contributions to the BE in models 1, 2, 3, and 5, respectively. The 
greater the number of residues directly involved in function, the greater the likelihood 
that crossovers break functionally important interactions. Another difference between my 
models and real proteins is the frequency, spatial distribution, and orders of the 
interactions that contribute to the BE. The existence of high order interactions affecting 
catalytic activity in real proteins has been verified experimentally [68-70]. High order 
interactions are particularly common in functionally important regions of proteins 
[68,71]. In some of my models, however, high order interactions are frequent relative to 
the size of the lattice protein and are distributed throughout its structure. Therefore, the 
most relevant way to interpret the lattice protein models in this study is to view them as 
models of the functionally important regions of larger proteins. This does not imply that 
they should be viewed specifically as active site models. Rather, they are models of the 
collection of residues that contribute to function.  
Future studies could possibly use larger lattice proteins to determine whether the 
nature of my results changes when at most 20-30% of the residues contribute to the BE 
and third order interactions are localized to the active site. Recall, however, that a single 
newly formed third order interaction is sufficient to grant chimeras greater evolvability 
than native lattice proteins (Figure 2.7). Thus, provided interacting residues are 
sufficiently spaced apart in sequence so that crossovers are likely to separate them, I do 
not expect the qualitative nature of my results to change significantly with larger lattice 
proteins and/or less interactions (provided they are at least third order).  
The major limitation of this work is that the native lattice proteins used in this 
study exhibit much greater diversity at their functional residues than is normally observed 
in the active sites of real homologous enzymes. The average sequence identity at the 
residues that directly contribute to the BE between the parents of a chimeric family 
ranges from 12-30% for the different lattice protein models. Instead, real homologous 
enzymes that perform the same catalytic chemistry and have similar substrate 
specificities often have nearly perfectly conserved active sites and most of their amino 
acid differences are found on their surfaces. Therefore, the resulting chimeras also have 
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conserved active sites [3,5,53]. Instead, the average sequence identity at the functional 
sites between chimeric lattice proteins retaining native levels of BE and their closest 
parent ranges from 60-85%. This suggests that the regions of real homologous enzymes 
that are directly involved in function are less tolerant to change than those of the lattice 
proteins of the present study. Thus, recombination of real enzymes cannot create non-
native interactions in the active sites. Instead, it relies on the existence of functionally 
significant long-range interactions between the surface and active site residues to form 
new interactions. Such long-range interactions have been observed in real proteins [72-
75] but their frequency and relative contribution to activity are likely to be less significant 
than functional interactions occurring within the active site. 
There are two factors that can contribute to the discrepancy between the diversity 
that is tolerated at the functional residues of lattice versus real proteins. The first is 
related to an inherent property of the BE models used in this study that may allow 
multiple sequences to be compatible with a high level of activity. More significantly, 
however, the discrepancy may indicate that the native lattice proteins of this study are 
less optimized relative to their fitness landscape than real native proteins are relative to 
theirs. A protein that is highly optimized relative to its fitness landscape is one that is 
almost globally optimized (i.e., better enzymes are extremely rare). I expect that 
diversifying the functional residues of such a protein without losing activity is extremely 
hard. Thus, a very reasonable explanation for the discrepancy between the sequence 
entropy tolerated at the functional residues of real versus native lattice proteins is that real 
proteins are more optimized than the native lattice proteins of the present study.  
To address this issue, future work should investigate how the number of 
generations used in the evolutionary simulations affects the nature of my results. 
Increasing the number of generations will produce native lattice proteins that are more 
optimized relative to their fitness landscape than the ones in the present study. In this 
scenario, I expect the diversity of native lattice proteins to decrease relative to the 
diversity observed in the present study. This will lead to a decrease in the number of non-
native interactions that can be formed using chimeragenesis and will reduce the 
likelihood that chimeric lattice proteins exhibit greater evolvability than their native 
counterparts. Alternatively, if the diversity of lattice proteins does not decrease 
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considerably, recombining highly diverse and highly optimized lattice proteins will lead 
to a great loss in BE, and it will not be possible to generate chimeric lattice proteins that 
have the same fitness as their parents like it was in this study. These arguments 
emphasize that, ultimately, it is the degree of optimization of native enzymes relative to 
their fitness landscape that determines whether chimeras can be more evolvable than their 
native parents. If they are highly optimized relative to their fitness landscape, then either 
1) their functional residues will be conserved and it will not be possible to recombine 
them and generate non-native functionally relevant interactions, or 2) their functional 
residues will not be conserved but it will be impossible to generate non-native 
interactions without suffering a big loss in fitness.  
These limitations are related to the underlying assumption of my hypothesis which 
is that native proteins are not globally optimized and that better proteins are frequent 
enough to be found using recombination and mutagenesis. This assumption is clearly 
satisfied in the present work. In general, however, we do no know whether it holds in real 
enzymes and only experiments can shed further light on this issue.   
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2.7 Supplementary Material 
 
Table 2.S1: Summary of the average value of the free energy of folding, 
 
"Gf , binding 
energy, 
 
BE , number of improved neighbors, 
 
nimp , greatest BE increments among 
improved neighbors 
 
"BEmax , BE after a steepest ascent walk, 
 
BESA , and number of 
steps taken to the nearest local maximum 
 
nsteps  for the sets 
 








































Model 1 -0.26 -0.25 -20.8 -20.8 10.3 3.3 -0.95 -0.70 -22.3 -21.6 2.3 1.4 




Table 2.S2: Summary of the average value of the free energy of folding, 
 
"Gf , binding 
energy, 
 
BE , number of improved neighbors, 
 
nimp , greatest BE increments among 
improved neighbors 
 
"BEmax , BE after a steepest ascent walk, 
 
BESA , and number of 
steps taken to the nearest local maximum 
 
nsteps  for the sets 
 








































Model 1 -0.28 -0.30 -23.1 -23.1 3.0 2.8 -0.65 -0.59 -- -- -- -- 
Model 2 -0.20 -0.21 -18.8 -18.8 10.5 8.2 -0.57 -0.49 -19.8 -19.6 2.9 2.5 
Model 3 -0.39 -0.40 -44.9 -44.9 9.0 4.1 -2.3 -0.90 -48.7 -46.8 3.2 2.7 










snat . The distributions are statistically indistinguishable. Top: model 1 (p = 1.0; p = 






Figure 2.S2: Chimeric lattice proteins (blue dots) and native lattice proteins (red dots) in 
 






Figure 2. S3: CDF of the free energy of folding of sequences in 
 
schi  and 
 
snat . The 
distributions are statistically indistinguishable. Top row: model 1 (p = 0.5; p = 1.0); 
second row: model 2 (p = 1.0; p = 1.0); third row: model 3 (p = 0.7; p = 1.0); last row: 







3 Evolvability of an Evolutionarily Young Chimeric 
Cellobiohydrolase II Derived from Trichoderma reesei, 




Cellulases are an important class of enzymes that catalyze the hydrolysis of cellulose to 
sugar. Unfortunately, they have specific activities on cellulose that are too low for the 
development of economically viable processes that convert biomass to sugar. Despite 
many efforts to further improve the specific activities of these enzymes, only minimal 
improvements in activity have been achieved. The present work proposes that highly 
mutated chimeric cellulases, assembled using homologous recombination, are more likely 
to have access to beneficial mutations than native ones of comparable activity because 
evolution has not searched their mutational neighborhood as it has in the case of native 
cellulases. The underlying assumption is that wild-type cellulases are locally optimized 
and that the constraints that hinder further improvement of their activities are 
evolutionary rather than physical. To test this hypothesis the mutational neighborhood of 
chimeric cellobiohydrolases II generated using SCHEMA structure-guided recombination 
was searched for beneficial mutations. Unfortunately, no mutants exhibiting a significant 
improvement in specific activity were found. The failure to identify improved mutants in 
the neighborhood of the chimeric cellulases can be attributed to 1) an unlucky choice of 
chimeras, 2) an assay poorly suited to identifying increments in specific activity, 3) a 
high degree of conservation in the functionally important regions of the cellulases in the 
SCHEMA library, or 4) a physical or chemical limitation to further improvements (i.e., 
native cellulases are globally optimized).  
 
3.2 Introduction 
Incentives to ameliorate the performance of natural cellulases are not lacking. Over 250 
million motor vehicles populate the United States accounting for 28% of our energy use 
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and 34% of our carbon dioxide emissions [78,79]. Petroleum, derived from depleting 
fossil fuels, powers most of those vehicles [79], and a significant portion of that 
petroleum is imported from countries that have unstable political and economic ties with 
the United States. Producing “clean” energy domestically from renewable resources is 
thus critical for both securing our supply and salvaging our environment. Cellulose is the 
most abundant renewable resource, and a study from the Department of Energy and the 
Department of Agriculture estimates that the United States can produce enough biomass 
to supply over 30% of our current oil demand without a dramatic negative impact on food 
supply [78].  
Cellulose degradation, however, is not easy. Cellulose is a linear condensation 
polymer consisting of D-anhydroglucopyranose joined together by ß-1,4-glycosidic 
bonds. Adjacent chains and sheets of cellulose are held together by hydrogen bonds and 
van der Waal’s forces resulting in a stable crystalline structure of great tensile strength 
and low accessibility [52]. The crystalline nature of cellulose makes it difficult to break 
down and requires the concerted attack of a team of enzymes acting synergistically and 
collectively referred to as cellulases. Endoglucanases hydrolyze accessible ß-1,4-
glycosidic bonds in amorphous regions of the polymer, disrupting its crystalline structure 
and exposing individual chain ends. Two different cellobiohydrolases-- one type working 
processively from the reducing end and the other from the non-reducing end of cellulose-
- then attack these individual chains and break them down to cellobiose. Finally, the 
cellobiose units are broken down to glucose by the actions of ß-glucosidases. Celluase 
systems come in two flavors: complexed and non-complexed. In non-complexed systems 
each of these enzymes is secreted individually from the cells. In complexed systems, 
(typical of anaerobic microorganisms), the enzymes are grouped into a complex known 
as the cellulosome that remains attached to the exterior cell wall. The present work is 
based on non-complexed cellulases.  
Grinding and pretreating naturally occurring cellulose with acids to disrupt its 
crystalline nature relieves some of the burden on cellulases, but introduces additional 
costs and waste treatment concerns. Furthermore, too much acid can damage the sugars 
[78]. Therefore, it is desirable to break down cellulose using more biology and less 
chemistry [78]. Currently, however, the bioconversion of natural cellulose to sugars by 
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organisms that secrete cellulases is too costly to be implemented for the large-scale 
production of biofuels. Strategies that will make this technology more economical 
include increasing the stability of cellulases at elevated temperatures and specific pH 
regimes and increasing their specific activity [52].  
Efforts to improve these enzymes are not lacking either: scientists and engineers 
have been working on the cellulase system of Trichoderma reesei (T. reesei) for over 50 
years. Since then, besides the wealth of literature describing the characterization of 
various natural cellulase systems, many groups have reported novel cellulases with 
altered pH profiles [53,80-83] or improved thermal tolerance [53,80,84-92]. For example 
Heinzelman et al. [53,90] recently created about 15 highly diversified chimeric 
cellobiohydrolases with thermostabilities higher than their most stable parent (which 
came from a thermophilic organism). A fairly accurate linear regression model predicts 
that hundreds of the designed (but uncharacterized) chimeras are thermostabilized with 
respect to the most stable parent.  
Despite the strong incentives and the many years of research on cellulases, efforts 
to improve the specific activities of cellulases have probably been the least successful. 
Using DNA shuffling Kim et al. [93] found a Bacillus subtilis endoglucanase mutant 
containing seven mutations with a five fold increase in specific activity on carboxymethyl 
cellulose (CMC) relative to the wild-type. While this may appear as a significant 
improvement, it has been shown that cellulase activities on soluble derivatives of 
cellulose such as CMC are poorly correlated with the activities on the naturally occurring 
insoluble cellulose [52]. McCarthy et al. [94] reported a modest improvement of 31% in 
the hydrolysis rate of a Thermotoga neapolitana ß-glucosidase single mutant on 
cellobiose found using random mutagenesis. Voutilainen et al. [85] recently reported the 
rational design of a cellobiohydrolase double mutant from the thermophilic fungus 
Talaromyces emersonii with an 80% improvement in the kcat/KM with respect to the 
soluble cellulase substrate, 4-methylumbelliferyl-ß-D-lactoside (mulAC). However, 
nearly all of the 80% improvement in kcat/KM can be attributed to a decrease in KM which 
translates to an increase in affinity for the non-natural substrate mulAC. In fact when they 
tested this mutant on microcrystalline cellulose (known commercially as Avicel) which is 
insoluble and has a significantly higher resemblance to naturally occurring cellulose than 
  
70 
mulAC, they found that the rates of hydrolysis of the mutant and the wild-type were the 
same. Escovar-Kousen et al. [95] reported the rational design of a single mutant of the 
cellulase Cel9A from Thermobifida fusca (T. fusca) with a 40% activity improvement on 
CMC and swollen cellulose (insoluble amourphous cellulose obtained using acid 
treatment). This, however, translated to no improvement on the more crystalline 
substrates, filter paper and bacterial microcrystalline cellulose (BMCC). Zhang et al. [96] 
studied the effects of 14 mutations in Cel6A from T. fusca involving six non-catalytic 
active site residues on a series of cellulolytic substrates varying in polymer length, 
crystallinity, solubility and charge. They only observed improvements on CMC. Zhang et 
al. [97] performed similar work on Cel6B from T. fusca and found a double mutant 
exhibiting two and three fold improvement on filter paper and swollen cellulose, 
respectively. They also found four mutants exhibiting up to a four-fold improvement on 
CMC. 
The achievements on the specific activities of cellulases on insoluble cellulose 
substrates are very modest. The challenge is at least in part a reflection of the fact that 
native cellulases have already been highly optimized by natural evolution to break down 
cellulose. While the stability and the pH profiles of an enzyme are not necessarily 
selected traits-- an enzyme need only be stable enough to function at the biologically 
relevant temperature and pH-- the high caloric value and the natural abundance of 
cellulose apply a significant selective pressure on microbes for its utilization. An 
organism that is well adapted to cellulose utilization will thrive in any habitat [98]. In fact 
cellulose hydrolysis limits the rate of microbial cellulose utilization as was inferred from 
the observation that microbial growth rates are several fold higher on soluble sugars than 
on crystalline cellulose [98]. Hence, evolution may have driven native cellulases to local 
maxima in their fitness landscape such that their mutational neighborhood does not 
contain any beneficial mutations, making directed evolution or any low-mutagenesis 
engineering approach (such as the rational design of a few active site residues) unlikely to 
succeed at improving the catalytic properties of these enzymes.  
The present work uses the cellulase platform and takes advantage of the existing 
library of highly diversified chimeric cellobiohydrolases II (Cel6A) constructed by 
Heinzelman et al. [53], to test the theory presented in chapter 2 that proposes that highly 
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mutated, non-native, chimeras are more evolvable than their native counterparts. The 
intuition is that non-native enzymes whose mutational neighborhood has not been 
searched by evolutionary processes are more likely to have access to beneficial 
mutations. However, whether this holds true for chimeric non-native enzymes whose 
building blocks are derived from native enzymes is not clear and is the subject of this 
study. The underlying assumption is that cellulases are not globally optimized.  
Random mutagenesis was used to generate mutants from chimeric and parental 
Cel6As. The number of improved mutants and their increment in specific activity are 
used as measures of evolvability. The former measure has been previously used by others 
[62] to quantify evolvability. The chimeric library of Heinzelman et al. [53] consists of 
three fungal Cel6As from Humicola insolens (H. insolens), T. reesei, and Chaetomium 
thermophilum (C. thermophilum) denoted as P1, P2, and P3, respectively, and the 
possible 6,558 chimeras that can be constructed from the seven crossovers designed by 
the structure-guided recombination algorithms SCHEMA and RASPP [2,4]. The Cel6As 
consist of a catalytic domain (CD) and a cellulose binding module (CBM) joined by a 
flexible linker. The crossovers occur in the CD, while the linker region and the CBM are 
the same in each member of the library and derived from the Cel6A of T. reesei. The 
CBM, CD and linker region contain a total of about 450 amino acids. Chimeric and 
native Cel6As were expressed in Saccharomyces cerevisiae (S. cerevisiae).  
SCHEMA and RASPP are structured-guided recombination algorithms that select 
the crossover locations that minimize structural disruption while maintaining a high level 
of sequence diversity. SCHEMA scores chimeras according to the number of non-native 
amino acids contacts formed upon recombination. Contacts are defined by a 4.5 Å 
structural cutoff. RASPP then directs crossovers to locations that minimize the average 
number of non-native contacts while maintaining a high average mutation rate in the 
chimeric library (please refer to the last section of the introduction to this thesis for more 
details on how SCHEMA and RASPP work). Members of the cellulase SCHEMA library 
have on average 50 mutations from their closest parent and 15 non-native contacts. 
Several highly mutated members of this library were shown to have the same level of 
specific activity on Avicel as their parent enzymes making this an excellent system to 
begin testing the theory of chapter 2 on real proteins. 
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In order for chimeric Cel6As to have access to more and better beneficial 
mutations than their wild-type counterparts, there must exist mutations that are beneficial 
in the context of the former but not the latter. This can occur only if mutations make non-
additive contributions to catalytic activity which means that the effect of a mutation 
depends on the presence or absence of other amino acids in the protein. When mutations 
make additive contributions to fitness, their effect is the same in any background and 
chimeras cannot gain access to beneficial mutations that are not beneficial in the context 
of a parental enzyme (denoted hereafter as new beneficial mutations). In order for 
chimeras to gain access to new beneficial mutations the effect of mutations must depend 
on at least two other residues (third order contributions to fitness) and the network of 
three or more interacting residues must be broken by the crossovers of recombination as 
illustrated in Figure 2.1.  
The existence of high order interactions affecting catalytic activity in real proteins 
has been verified experimentally [68-70]. Nevertheless, it has been argued that mutations 
exhibit mostly additive effects in proteins and that high order contributions to fitness are 
rare [64,71]. These studies are often based on double mutant cycle analyses, in which two 
mutations are found to be independent of one another (and thus to exhibit additivity) 
when the contribution to fitness of the double mutant is equal to the sum of the 
contributions of the single mutants [71]. When this condition is not met the effect of one 
mutation depends on the presence of the other, and the two residues form a pair-wise 
interaction. Mutations are likely to exhibit non-additive effects when they are in direct 
contact in the protein structure [71,99,100]. Since most proteins are large, two randomly 
chosen amino acids are unlikely to be in contact and thus to exhibit non-additivity 
[64,101]. Thus if one were to perform double mutant cycle analyses [102] on all possible 
amino acid pairs in a protein, the outcome would be that most pairs exhibit additivity. 
Chimeras, however, already contain many mutations relative to their parents. Any 
further mutations that are introduced into their structure are likely to occur in the 
proximity of other mutations and thus to exhibit non-additive effects (i.e., to make 
different contributions to fitness in chimeric versus native backgrounds). This, however, 
does not hold true for all heavily mutated chimeras. Consider a chimera with a single 
crossover that inherits its N-terminal half from one parent and its C-terminal half from 
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another parent. Such a chimera is heavily mutated (the number of mutations relative to its 
closest parent is high) but, because it is composed of two large native segments, any 
mutation will likely occur in a native, non-mutated local environment and exhibit 
additivity unless it occurs at the interface of the segments. This reasoning reemphasizes 
the importance of creating non-native interactions to gain access to new beneficial 
mutations and benefit from non-additivity. Creating too many non-native interactions, 
however, will compromise the activity of the chimera. Whether chimeras are sufficiently 
diversified to gain access to new beneficial mutations without significantly disrupting the 
function of the enzyme is not clear. Finally it is important to keep in mind that SCHEMA 
[2] is based on the principle of conserving native interactions to preserve structural 
integrity. This further reduces the probability that the library crossovers create new 
interactions. 
According to the high-resolution crystal structure [103] of the CD of the H. 
insolens parent, the active site is highly conserved among the three parent cellulases. Of 
the 39 amino acids that are within 4.5 Å of the substrate, only one is not conserved 
among the three parents. Active site mutations are thus likely to make the same 
contributions to activity in chimeric and parental backgrounds. Therefore long-range 
interactions with the active must exist in order for chimeras to gain access to new 
beneficial mutations with respect to catalytic activity. There are numerous reports in the 
literature of non active site mutations that can affect catalytic activity via long-range 
interactions with the active site [72-75], but whether they exist in the Cel6A scaffold is 
not clear.  
To determine whether SCHEMA chimeras can exhibit greater evolvability than 
their parents despite these limitations, the activities on cellulose of point mutants within 
the mutational neighborhood of native and chimeric Cel6As were determined and 
compared. The number of clones exhibiting improved specific activity on Avicel and the 
magnitude of the activity increment was used as the sole measure of evolvability. 
Random mutagenesis of two native Cel6As and four chimeric Cel6As was used to 
explore their mutational neighborhood. The genes of these enzymes were amplified and 
mutated by error-prone PCR. The plasmids bearing the mutated genes were then 
transformed into S. cerevisiae and their whole cell activities on Avicel were determined 
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using a high-throughput screen recently developed in our lab. A whole cell activity screen 
is one in which a fixed amount of the cell culture supernatant is used in the screen and 
thus does not account for differences in protein expression. For this reason, further 
characterizations must be performed on the best mutants to verifiy improvements in 
specific activity (activity per unit mass of enzyme). No clones exhibiting improved whole 
cell activities were found in the native libraries, whereas several were found in the 
chimeric libraries. The best clones from one of the chimeric libraries were recombined 
and the top hits from the recombination library were purified and their specific activities 
on Avicel measured. Specific activity assays are performed with a fixed amount of 
protein so that differences in protein expression are accounted for. Unfortunately, the 
improvements in specific activity were very modest, and most of the increase in whole 
cell activity could be attributed to an increase in expression level.  
 
3.3 Results 
3.3.1 Selection of Chimeras 
In order to compare the evolvabilities of chimeric and native Cel6As of equal fitness, it 
was necessary to first identify a set of chimeras that have thermostabilities and activities 
comparable to their parent enzymes. It is important to control for thermostability because 
stable enzymes can tolerate destabilizing mutations that are not accessible to less stable 
enzymes but may be beneficial with respect to catalytic activity [62]. To this end 38 
previously characterized chimeras [53] with stabilities comparable to those of their 
parents were selected and assayed on Avicel along with P1 and P3 using the whole cell 
high-throughput Avicel assay described in the experimental methods (EM). Avicel is 
considered by many researchers to be a good substrate for exoglucanase activity because 
it is highly crystalline and it has a high fraction of free reducing ends relative to the 
fraction of accessible ß-glucosidic bonds [52,104].   
Table 3.S1 in the supplementary material (SM) lists the sequences and stabilities 
of the 38 chimeras and two parents used in this initial characterization. The chimeric 
sequences are reported in terms of the parent from which each of the eight sequence 
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fragments is inherited. For example chimera 31111112 inherits its N-and C-terminal 
fragments from P3 and P2, respectively, and all its internal fragments from P1. Stability 
is reported in terms of T50, the temperature at which an enzyme loses 50% of its activity 
after a 10 minute incubation [90]. P2 was omitted from this initial characterization 
because its extremely low level of expression in S. cerevisiae would not allow its activity 
to be detected by this assay. The cells bearing the P3 gene did not grow for the initial 
characterization. P3 was thus tested in second assay. The assay was performed at five 
different temperatures: 45, 50, 55, 60, and 65°C. Each enzyme was assayed twice on two 
different assay plates.  
Six chimeras were found to have whole cell activities comparable to P1 over the 
entire range of temperatures. These results are shown in Figure 3.1. The selected 
chimeras, P1, and P3 were then reassayed at 50°C and the results are shown in Figure 
3.2. This was done by plating a 10 µl aliquot of the remaining supernatant from the 
culture onto a fresh SD-URA plate. Colonies were allowed to grow for 72 hours at 30°C 
and then sixteen individual colonies were used to inoculate sixteen wells of two 96-deep 
well plates containing 50 µl of SD-URA. Growth, expression, and assaying from this 
point on are described in the EM. The low temperature of 50°C was chosen as the 
temperature for all subsequent activity tests to 1) reduce the likelihood of selecting 
stabilizing mutations over activity enhancing mutations and to 2) reduce the bias in 
evolvability arising from native and parental enzymes having different thermostabilities. 





Figure 3.1: Relative amount of cellobiose formed by the six chimeras having the same 
whole-cell activity as P1. P2 was omitted from this initial characterization because its 
extremely low level of expression in S. cerevisiae would not allow its activity to be 
detected by this assay. The cells bearing the P3 gene did not grow and this enzyme was 
tested in a subsequent assay (Figure 3.2). The error bars represent the difference between 
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Figure 3.2: Cellobiose formed relative to P1 at 50°C. The yellow bars represent the data 
from Figure 3.1. The purple and blue bars represent the data from the second assay of 
plates 1 and 2, respectively. The error bars of the purple and blue bars represent the 
standard deviations across the 8 measurements of the plate. The discrepancy in HJ+ 
activity is related to using the HIS6-tagged version of this chimera in the second assay. 
 
Another important criterion to consider when selecting the chimeras is the degree 
to which they differ from their parents. As stated in the introduction and emphasized in 
chapter 2, chimeras gain access to new beneficial mutations when non-native interactions 
are formed. For each of the chimeras of Figures 3.1 and 3.2 the number of mutations 
from their closest parent, m, the number of non-native pair-wise interactions, E, and the 
number of non-native third order interactions, E3, were calculated and shown in Table 
3.1. Interactions are defined by a 4.5 Å structural cutoff. In a third order interaction each 
residue is within 4.5 Å of the other two residues. A mutation that occurs in a non-native 
network of three or more interacting residues can potentially exhibit non-additive effects 
because it leads to a combination of amino acids that are not accessible to parental 
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Cel6As (Figure 2.1). The T50s and the relative whole cell activities on Avicel are also 
shown.  
 
Table 3.1: Summary of the m, E, E3, T50 and the whole cell activity on Avicel relative to 
P1, RAP1, for the chimeras of Figures 3.1 and 3.2. The values of the relative whole cell 
activities correspond to the average across the first and second assay. The value presented 
for HJ+ corresponds to the value obtained from the first assay since the HIS6-tagged 
version was accidentally used in the second assay. The values for all the other cellulases 
are also based on the non-tagged enzymes. 
enzyme m E E3 RAP1 T50 
12-22232132 48 18 16 0.95±0.11 68.0 
18-13231111 27 4 2 0.79±0.09 63.3 
41-12133333 35 13 12 0.67±0.09 64.0 
89-11113332 41 5 1 0.63±0.14 70.0 
90-12113132 48 15 10 0.63±0.14 70.5 
HJ+-12222332 47 14 11 1.15±0.06 71.0 
P1-11111111 0 0 0 1 64.8 
P2-22222222 0 0 0 -- 59.0 
P3-33333333 0 0 0 0.47±0.00 64.0 
  
Chimeras HJ+ and 12 were chosen because their whole cell activity levels are 
comparable to P1 and they have the highest values of m, E, and E3. Chimera 90 was 
chosen because it has the next highest values of m, E, and E3. Chimera 89 was not 
intended to be included but a labeling error caused its inclusion. 
3.3.2 Characterization of the mutational neighborhood of the selected 
chimeras using random mutagenesis. 
The genes of P1, P3, and chimeras 12, 89, 90, and HJ+ were amplified using error-prone 
PCR. The frequency of mutations can be controlled by varying the concentration of 
MnCl2. For each enzyme, error-prone PCR was performed using concentrations of MnCl2 
of 150, 200, 250, and 300 µM as described in the experimental methods (EM). The 
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collection of mutants obtained for each enzyme and concentration of MnCl2 are referred 
to as a library.  
In order to determine the library with an appropriate mutation rate, 88 mutants 
from each of the libraries containing 150, 200, and 250 µM MnCl2 were screened in 96-
well plates using the high-throughput whole cell Avicel screen as described in the EM (a 
total of 6x3 = 18 plates). The library with [MnCl2] = 300 µM was omitted from this initial 
characterization because it was assumed that this high concentration was unlikely to yield 
a sufficient fraction of functional clones. Clones were defined to be functional if their 
absorbance reading at 520 nm was 0.05 AU above the blank wells. This value 
corresponds to the minimum increase in absorbance relative to that of the blank required 
for this difference to be visible to the eye. For comparison this corresponds to about 15% 
of the whole cell activity of P1. The fraction of functional clones in the libraries with 
concentrations of MnCl2 of 150, 200, and 250 µM was found to be 36 ± 3%, 29 ± 5%, 
and 15 ± 3%, respectively. Thus the library with [MnCl2] = 150 µM was chosen for 
further characterization. A total of 600 clones were screened from each of the six libraries 
and clones exhibiting an increase of 20% or greater relative to their parents were chosen 
for a re-screen. A total of 0, 3, 9, 3, 12, and 7 clones were chosen from the P1, P3, 12, 89, 
90, and HJ+ libraries to be re-screened. Clones exhibiting an average of 20% or better 
















Table 3.2: Summary of the m, E, E3, T50 , the whole cell activity on Avicel relative to P1 
( RAP1) of the chimeras used to generate the random mutagenesis libraries, the number of 
improved mutants found in each library, and the improvement of each mutant relative to 
the enzyme it was derived from.  
Enzyme T50 RAP1 m/ E/ E3 # improved clones % improvement 
12-22232132 68 1.0 48/18/16 3 21% 
20% 
20% 
89-11113332 71 0.6 41/5/1 2 28% 
22% 
90-12113132 70 0.6 58/15/10 0 -- 
HJ+-12222332 71 1.2 47/14/11 1 24% 
P1-11111111 65 1 0/0/0 0 -- 
P3-33333333 64 0.5 0/0/0 0 -- 
 
The results in Table 3.2 show that all clones exhibiting improvement on Avicel 
are derived from chimeras. These improvements, however, can be attributed to either an 
increase in expression, stability, specific activity, or a combination of these three 
properties and further characterizations are necessary to verify any improvement in 
specific activity.  
Only 600 clones were screened from each of the above libraries because the 
transformation efficiencies were poor. To obtain results of greater statistical significance, 
it was necessary to characterize a larger fraction of the neighborhood of each enzyme. To 
this end a new set of libraries was generated with concentrations of MnCl2 of 50, 100, 
150, 200, 250, 300, and 350 µM. Additionally, a mutated version of P2, P2C311S, was 
included because it was found that the C311S mutation increased expression by nearly 10 
fold (a total of 7x7 = 49 new libraries were created). It was important to include this 
parent because chimeras 12 and HJ+ are more closely related to P2 than they are to P1 
and P3. A fair comparison of the evolvabilities of these two chimeras relative to that of 
the parental enzymes would have to involve P2 or its closely related mutant P2C311S.  
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Instead of screening a large number of clones from all seven libraries, it was 
decided to screen 3,000 clones from the most promising chimeric library, and then 
recombine, purify, and characterize the specific activity of the best hits, proceeding to 
screening other libraries if positive results were found. The library from chimera 12 was 
chosen because 1) its T50 is closer to that of the native enzymes, 2) its specific activity is 
comparable to that of its closest parent, P2C311S (Figure 3.5), 3) it has the highest values 
of m, E, and E3, and 4) it gave rise to the greatest number improved clones in the initial 
characterization of 600 members of its neighborhood. To determine the library with the 
appropriate amount of mutations, a single 96-well plate from each of the seven libraries 
derived from chimera 12 containing different concentrations of MnCl2 was assayed using 
the high-throughput Avicel screen. The fraction of functional clones was 81%, 65%, 
64%, 68%, 37%, 36%, and 8% in the libraries containing 50, 100, 150, 200, 250, 300, 
and 350 µM MnCl2, respectively. Because of the large gap in functional clones between 
the library containing 200 µM MnCl2 (68% functional) and the library containing 250 
µM MnCl2 (37% functional) it was decided to screen 3,000 clones from each. A total of 
20 clones exhibiting an improvement of 20% or better were selected for the re-screen. 
The improvements relative to chimeras 12, P1, P2C311S, and P3 of the top five clones in 
the rescreen are shown in Figure 3.3. Their non-synonymous mutations and relative 
improvement are summarized in Table 3.3. The locations of the mutations are shown in 



























Figure 3.3: Product formed by the best five mutants found in the libraries derived from 
chimera 12 with [MnCl2] = 200 and 250 µM. The values are based on the re-screen data 
(whole cell activity). Error bars represent the standard deviation across eight independent 
measurements.  
 
Table 3.3: Summary of the mutations in the five clones selected from the re-screen and 
the relative improvement they provide relative to chimera 12, RAC-12, based on the whole 
cell screen on Avicel. Underlined mutations occur in the linker region and mutations in 
bold appear in more than one selected clone. Numbering is based on the 1OCN structure 
[103].  
Clone RAC-12 Mutations 
P103C 22% D282E 
P2E4 23% P283L, S410P 
P8F9 32% N290D, V398A 
P12D12 28% Y93N, N290D, N445Y 





Figure 3.4: Locations of the best five mutations from the re-screen. The structure is 
based on the 1OCN structure [103]. The substrate, a cellobio-derived isofagomine 
glycosidase inhibitor, is shown in grey. The portions of the structure shown in red, 
yellow, and blue represent those derived from P1, P2, and P3 respectively. Mutations are 
shown in magenta.  
 
Figure 3.4 shows that most mutations occur on the surface of the enzyme, with the 
exception of mutation V398A that occurs in the active site and is within 5.6 Å of the 
substrate. This residue is conserved in the three parents. This residue is in contact with 
seven other residues, but these are perfectly conserved in the three parents. It is also 
involved in eight third order interactions (three residues that are within 4.5 Å of each 
other) that are also perfectly conserved in the three parents. Thus, the V398A mutation 
occurs in a very native environment and can only make non-additive contributions to 
fitness if it is involved in long-range interactions with mutated residues. The same is true 
for all other mutated residues with the exception of residue D282. Residue D282 is 
involved in a third order interaction with residues Q286 and R345 in the background of 
chimera 12. These residues are QER, DQH, and QEQ in P1, P2, and P3, respectively. 
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The mutation D282E thus leads to a combination of amino acids, EQR, not accessible to 
any of the parental cellulases. However, D282E is a surface mutation and it is only via 
long-range interactions with the active site that this newly formed third order interaction 
can affect catalytic activity. Because the improvements in whole cell activities are not 
very high, the identified mutations were recombined with the purpose of selecting, 
purifying, and determining the specific activities of clones with improved whole cell 
activities of at least 50%.  
3.3.3 Recombination of the mutations in the best five mutants. 
The mutations in Table 3.3 were recombined using overlap extension PCR as described 
in the EM to create all possible 29 = 512 combinations of amino acids. Over 2,000 clones 
were screened (four-fold over sampling) and the 18 clones exhibiting an improvement of 
30% or better were re-screened. The top six clones with relative improvements of 57 
(2C), 59 (3D), 57 (6D), 56 (7D), 54 (7G), and 54% (8E) with respect to the whole cell 
activity of chimera 12 were chosen for further characterization. The mutations found in 
these clones are summarized in Table 3.4.  
 
Table 3.4: Summary of the mutations identified in the six best clones from the 





























2C * * * *  *  *  
3D * * *  *  *   
6D * *  *      
7D * * * * * *  *  
7G * * * * *    * 
8E * * * * *  *   
 
Table 3.4 shows that two of the nine mutations, N290D and D282E, appear in all 
the selected clones. Mutations S410P and T73A occur in five of the six selected clones. 
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The active site mutation V398A appears in four of the six clones. Mutations P283L, 
V440A, and Y93N appear in two of the six clones and mutation N445Y appear in one of 
the six selected clones.  
 To determine the specific activity of the selected clones on Avicel they were 
tagged with six histidines (HIS6) on their C-terminus, purified, and their specific activity 
on Avicel measured as described in the EM. The accuracy of the HIS6 constructs was 
verified by sequencing. The concentrations were determined by measuring the 
absorbance at 280 nm and using the molar extinction coefficient of 92,425 M-1cm-1 [105] 
as described in the EM. The purification profiles, the SDS PAGE gels of the purified 
proteins, and the absorbance readings at 280 nm plotted as a function of volume of 
purified protein are shown in Figures 3.S1-3.S3 in the SM. To determine the errors in the 
measurement of the specific activity related to the process of purification, buffer 
exchange, and determination of concentration, the entire procedure was repeated 
independently twice for clone 6D, chimera 12, and P2C311S. The specific activity was 
measured using 300 nM protein, 50 mg/ml Avicel, and 80 mM NaCl for 2 hours at 50ºC 
as described in the EM. The specific activities of the clones are compared to chimera 12 
and to parent P2C311S (the parent exhibiting greatest homology to chimera 12). The 

















































Figure 3.5: Specific activity (mM cellobiose/min/mg protein) of the top five clones from 
the recombination library, the top clone, P8F9, from the random mutagenesis library, 
chimera 12, and parent P2C311S. Two bars are shown for mutant 6D and parent 
P2C311S corresponding to the two independently purified batches. The specific activity 
was measured using 300 nM protein, 50 mg/ml Avicel, and 80 mM NaCl for 2 hours at 
50ºC as described in the EM. The error bars represent the standard deviation across six 
independent measurements.  
 
Figure 3.5 shows that the improvements in specific activity relative to chimera 12 
are very modest and range from 5-10%. The improvements based on the whole cell 
activity assay ranged from 54-59%, suggesting that the bulk of the improvement can be 
attributed to an increase in expression. Figure 3.S1 in the SM shows the purification 
profiles of chimera 12, parent P2C311S, clone 6D, and clone 7D. These proteins were 
grown and purified in parallel under identical conditions so that the relative size of the 
peaks in the purification profile are an indication of their expression. Supplemental 
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Figure 3.S1 suggests that clones 6D and 7D are more highly expressed than their parent, 
chimera 12.  
The improvements in specific activity are rather low but could be reproduced on 
different days and under different assay conditions (data not shown). The independently 
purified batches of mutant 6D show great consistency in specific activity: 2.5 ± 0.1 and 
2.4 ± 0.1 mM/min/mg. The consistency of the two P2C311S batches is not as good, 1.7 ± 
0.1 and 2.0 ± 0.2 mM/min/mg, but still acceptable. To determine whether the increments 
in specific activity could be attributed to an increase in thermal stability the fraction of 
enzyme remaining functional after various incubation times at 50°C was determined as 
described in the EM. Briefly, identical protein samples containing 1.8 µM protein were 
incubated at 50°C for 0, 3, 6, and 9 hours. The samples were then screened on Avicel at 
30°C for 2 hours. The high protein concentration was necessary to obtain a reliable signal 
at the low assay temperature of 30°C. This experiment was performed on chimera 12, 






Figure 3.6: Relative Avicel activity remaining at 30°C after different incubations times at 
50°C. Identical protein samples containing 1.8 µM proteins were incubated at 50°C for 0, 
3, 6, and 9 hours and then screened on Avicel for 2 hours at 30°C.  
 
Figure 3.6 shows that after as long as nine hours of incubation at 50°C the 
proteins still retain 100% of their activity. This excludes the possibility that the small 
increments in specific activity are the results of stabilizing mutations. To verify whether 
the increments in specific activity lead to a detectable increase in initial rate of reaction 
the initial rates of reaction on Avicel were determined as described in the EM for chimera 
12, parent P2C311S, and clone 6D. The Park-Johnson assay [106] described in the EM 
was used instead of the Nelson-Somogyi [107,108] method because it is more suited to 
measuring the low concentrations of cellobiose that are reached during the first three 
minutes of the reaction. Each protein was tested twice, using the two independently 
purified batches of chimera 12, parent P2C311S, and clone 6D. The results are shown in 
Figure 3.7. The rate of reaction was measured during the first three minutes after the 
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addition of the protein to a pre-heated Avicel sample. Measurements were taken every  






















Figure 3.7: Initital rates of reactions for chimera 12, parent P2C311S, and clone 6D. The 
profile of clone 6D-2 extends to 180 s because the time point at 60 s was accidentally 
missed. Reactions were carried out using 300 nM protein, 134 Mm NaCl, and 10 mg/ml 
of Avicel at 50°C in 50 mM sodium acetate buffer (pH = 5.0). 
 
Figure 3.7 shows that the small increment in specific activity observed in clone 6D 
cannot be detected in the initial rate of reaction. Although this was not repeated for the 
remaining mutants, their similarity in sequence (Table 3.4) and in specific activity to 
clone 6D strongly suggests that their initial rate of reaction profile will not exhibit 





The experiments described in this chapter aimed to generate experimental evidence that 
chimeric enzymes have access to more and better beneficial mutations than their wild-
type counterparts. This hypothesis was tested in the context of a previously characterized 
library of chimeric Cel6As [53]. The chimeras of this library differ, on average, by 50 
amino acids relative to their closest parent. However, whether their mutational 
neighborhood is effectively unexplored by evolutionary processes is unclear because their 
building blocks are derived from native enzymes. To reduce bias arising from differences 
in fitness between the chimeras and their parents, the chimeras used in this study have 
activities on Avicel and stabilities comparable to those of their parents.  
The mutational neighborhood of four chimeric and two native Cel6As was searched 
for mutants with improved whole cell activities on Avicel. All clones exhibiting 
improvements were derived from chimeric parents and none could be found in the 
parental libraries. Following this initial characterization, 6,000 clones in the 
neighborhood of chimera 12 were screened on Avicel. The best five mutants exhibited 
improvements in whole cell activity ranging from 22-32%. Their nine mutations were 
recombined using overlap extension PCR and 2,000 clones from this library (roughly 4-
fold over sampling) were screened on Avicel. The best six clones, exhibiting whole cell 
activity improvements ranging from 54-59%, were purified and their specific activity on 
Avicel characterized. The improvements in specific activity were very modest, ranging 
from 5-10%, implying that the bulk of the ~55% whole cell activity improvement was the 
result of an increase in cellulase expression as also suggested by the purification profiles 
of Supplemental Figure 3.S1. It was verified that these improvements were not the result 
of stabilizing mutations. However, it was not possible to detect a faster rate of initial 
reaction. This was not surprising as increases in specific activity of only 5-10% over the 
course of a two hour reaction are unlikely to be detectable in the first three minutes of 
reaction. Furthermore, the improvements in specific activities may be an artifact arising 
from errors in the measurement of active cellulase concentration. As shown in the SDS 
PAGE gels of the purified proteins, there is an unidentified band at 30 kDa that 
contributes to the measured concentration of the purified cellulases. While this band is 
rather faint, and appears to be relatively uniform across the protein samples, the specific 
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activity improvement is so low that its mere existence is extremely sensitive to 
experimental errors. Finally, supposing that the improvements in specific activity are real, 
they do not represent progress on mutagenesis studies performed on native cellulases 
because increments in specific activity of 5-10% or more have already been reported.  
Provided native enzymes are locally optimized, non-native enzymes will always 
have, on average, access to a greater number of beneficial mutations than native enzymes. 
The expected number of beneficial mutations accessible to locally optimized native 
enzymes is zero. For any non-native enzyme this number is strictly greater than zero, 
independently of fitness. Ultimately, however, to find a single beneficial mutation in the 
neighborhood of a chimera, this number must be greater than or equal to one. Therefore, 
besides an unlucky choice of chimera, the failure to identify sufficiently strong beneficial 
mutations (i.e., > 50% improvement in specific activity) in the neighborhood of chimera 
12 can be attributed to 1) a low frequency of beneficial mutations within the reach of 
chimeras from this library or 2) a low frequency of beneficial mutations in the entirety of 
sequence space. Additionally, the high-throughput Avicel screen may be inadequate for 
selecting mutants with improved specific activity. The first two scenarios and the 
limitations of the Avicel screen are discussed in more detail below.  
 
3.4.1  Beneficial Mutations within the Reach of the Chimeras from the 
SCHEMA Cel6A Library are too Rare to be Found 
In order for chimeric Cel6As to have access to more and better beneficial mutations than 
their wild-type counterparts, there must exist mutations that are beneficial in the context 
of the former but not the latter. The last two chapters have emphasized the necessity to 
create new, non-native functionally important third or higher order interactions in order 
for this to occur. Thus, supposing that sequences encoding Cel6As that have higher 
activity than wild-type Cel6As exist in sequence space and are frequent enough to be 
found, the probability that they can be found using recombination depends on 1) the 
significance and frequency of functionally important high order interactions in the Cel6A 
scaffold, and 2) the likelihood that such interactions are broken by the crossovers of 
recombination to form, new, non-native interactions that make, on average, a neutral 
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contribution to fitness. Neutrality is important because, in general, forming new 
interactions will have a deleterious effect on protein function [77] and, in addition to 
trivializing the hypothesis, it is unlikely that any benefit can be derived from a chimera 
that is more evolvable but significantly less fit than a native enzyme. 
Protein landscapes have often been described as “smooth” or “roughly additive.” 
These conclusions are mostly derived from experimental observations that the 
contribution to fitness of a double mutant is often equal to the sum of the contributions of 
the individual mutations [71]. These results, however, usually break down when 
mutations are adjacent to one another in three dimensional space [71,99]. This reflects the 
fact that, unless long-range interactions are frequent and significant, high order 
contributions to fitness can only be detected when mutations are recruited into a non-
native environment. Therefore, high order interactions could be extremely common and 
yet have gone unnoticed by double mutant cycles analyses in which the effects of just a 
few mutations at a time are evaluated.  
Additivity has also been observed in many directed evolution studies in which 
beneficial mutations were accumulated one at a time and found to be independent of one 
another. However, Weinreich et al. [69], showed that only 18 of the possible 120 paths 
linking two ß-lactamases differing by five mutations and five orders of magnitude in 
antibiotic resistance conferred to bacteria were possible by adaptive evolution. Thus 102 
out of the 120 paths linking the two enzymes and exhibiting non-additivity would never 
be found by a standard directed evolution study. Similar results were observed in [70]. 
Furthermore, additivity has been primarily verified with respect to thermostability 
[101,109].  When contributions to catalytic activity are being considered rather than 
contributions to stability (as is the case in the present study) non-additive effects become 
much more frequent [68-70,99]. Da Silva and co-workers [68], for example, showed that 
non-additivity was common, and often involved third or higher order interactions in a 
functionally important region of an HIV glycoprotein. Therefore, high order interactions 
do exist in sequence space and are possibly more frequent than expected.  
In order for chimeras to have access to new beneficial mutations, the crossovers 
of recombination must break functionally important interactions and replace them with 
new ones that make neutral contributions to fitness. In the chimeras of the SCHEMA 
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Cel6A library, however, the active site is largely conserved making it impossible to break 
functionally important interactions within the active site. Numerous studies have reported 
catalytically important mutations that occur remotely from the active site [72-75]. In one 
study directed evolution was used to change the substrate specificity of aspartate 
aminotransferase. The mutant enzyme had a 106 fold increase in the kcat/KM on the non-
native substrate valine. Only one of the 17 acquired mutations was in contact with the 
substrate. The three dimensional structure of the mutant enzyme bound to a valine analog 
showed that the remote mutations caused structural alterations in the active site and 
surroundings [72]. Thus, despite the conserved active site in the Cel6A library, mutations 
acquired on the surface of the chimeras may cause structural rearrangements that give 
them access to catalytically beneficial mutations that are not accessible to their parents. 
However, since the mutations acquired on the surface of the chimeras are derived from 
homologous enzymes, they may be unlikely to significantly alter their structural features. 
Additionally it is important to keep in mind that while the chimeras in the library are 
heavily mutated, they are only mildly disrupted by design. The SCHEMA algorithm 
minimizes local disruption by selecting crossovers that maximize the conservation of 
amino acids between the interfaces of the recombination fragments to minimize the 
number of non-native contacts formed upon recombination. One consequence of this is 
that the fragments make additive contributions to thermostability [17]. Another 
consequence may be that structural rearrangements that can alter the catalytic effects of 
mutations are highly unlikely.  
Furthermore, chimeras that have roughly the same activity as their parents, such 
as those in the present study, are likely to contain less disruption than the average 
chimera in the library because, in general, non-native contacts are deleterious. Non-native 
contacts that make neutral contributions to fitness are less common. In fact, the six 
chimeras that were chosen because of their similarity in fitness to the native Cel6As have, 
on average, lower m and E, than the average m and E of the 38 chimeras they were 
selected from as shown in Figure 3.S4 in the SM. Thus, while it is desirable to break 
interactions to gain access to novel combinations of amino acids, too much disruption 
leads to poorly active chimeras, limiting the number of possible broken interactions. All 
of these limitations, combined with the reality that beneficial mutations are rare, may 
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make it extremely unlikely for SCHEMA to gain access to new beneficial mutaitons.  
The fact that no significantly beneficial mutations were found in the neighborhood of 
chimera 12 supports this conclusion.  
 Alternatively to homologous recombination, novel enzymes with unexplored 
mutational neighborhood may be generated using de novo design. In 1997 Mayo and co-
workers pioneered the first fully automated design and experimental validation of a novel 
sequence for an entire protein. Using computational methods, they completely redesigned 
the sequence of a 28-residue zinc finger using an algorithm that used as input only the 
backbone fold and had no knowledge of the naturally occurring sequence. Their final 
designed sequence was shown to properly fold to the target structure despite very low 
sequence identity (21%) with the naturally occurring sequence [110]. Baker and co-
workers extended this work to the complete redesign of nine globular proteins [111]. 
Again, their modeling algorithm had no knowledge of the natural sequences and used 
only the backbone structure to design the novel sequences. On average 65% of the 
residues in the designed sequences differed from wild-type over all protein residues and 
50% differed from wild-type in the core. Yet eight out of the nine designs encoded 
properly folded proteins. In one case, the designed sequence encoded a protein that was a 
striking ~7 kcal/mol more stable than the corresponding wild-type. This technique could 
be used to design highly mutated cellulases based on the Cel6A backbone fold. Enzyme 
size would be the major limitation. The CD of cellulases is approximately 360 residues 
long while the designs by Baker and co-workers spanned at most 100 residues. 
In 2008, Baker and co-workers [112] successfully designed eight enzymes with 
two different catalytic motifs that could catalyze the Kemp elimination reaction. If it is 
possible to design a novel enzymatic function, it may be possible to preserve an existing 
native one while simultaneously diversifying the active site. In the case of the Cel6As, 
this could be done by preserving the key catalytic residues, while mutating the active site 
in such a way that does not create steric hindrance with the substrate. If this is done with 
sufficient care, it may be possible to preserve most of the native activity while strongly 
diversifying the sequence of the designed enzyme- both on the surface and in the core. 
This approach may bypass the limitations of chimeragenesis because the designed 
enzymes would not have large portions of their structure identical to those of native 
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enzymes. If this were to succeed for several independent designs, while it would not 
guarantee that the activity of the non-native enzymes could be improved beyond that of 
their native counterparts, it may shed light on the distribution of activities in the cellulase 
landscape. 
 
3.4.2  Fitness Peaks Taller than the Native Peak are Rare in Sequence Space 
The hydrolysis and utilization of cellulose is widely distributed among many genera in 
the domain Bacteria and in the fungal groups within the domain Eucarya. Recently, it has 
been discovered that certain animal species, including crayfish and termites, produce 
their own cellulases [98]. Currently, there are hundreds of known genes encoding 
enzymes with cellulolytic activity. Often they exhibit fairly different folds. The 
abundance of cellulose, the strong selective pressure conferred to any organism capable 
of utilizing it efficiently, and the rich reportoire of identified cellulases could suggest that 
these enzymes have been highly optimized by natural evolution to degrade cellulose. 
However, cellulases appear to be much less active on their native substrate than their 
related glycoside hydrolases [98,113] are on their native substrates. Klyosov [113] 
calculates kcat values of 0.5 to 0.6 s-1 for T. reesei cellulases, 58 s-1 for amylase, and up to 
100 to 1,000 s-1 for other hydrolases. Another example is the specific activity of a T. 
reesei cellulase on crystalline cellulose (filter paper) which has been found to be 100 fold 
lower than that of amylase on starch [114].  
Cellulase activity on soluble or pre-treated cellulose substrates is generally higher. 
For example Bernardez et al. [115] compared initial hydrolysis rates of a Clostridium 
thermocellum cellulase system on Avicel and dilute-acid-pretreated mixed hardwood. 
Pretreated wood was hydrolyzed up to 10-fold faster than Avicel. Similarily, Zhang and 
coworkers [116] found that the initial hydrolysis of PASC (phosphoric acid swollen 
cellulose) is more than 100 fold higher than that of Avicel. In fact, available data suggests 
that the specific activity of exo-acting saccharolytic enzymes on comparable substrates is 
similar. For example the specific activity of the T. reesei Cel6A on cellohexaose is highly 
comparable to that of a Aspergillus awamori glucoamylase on maltohexaose [116]. These 
arguments may imply that the recalcitrant nature of microcrystalline cellulose poses a 
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physical limitation to further improving the specific activity of cellulases (i.e., native 
cellulases are globally optimized) or that, alternatively, native cellulases are not globally 
optimized but better cellulases are so rare and distant in sequence (and perhaps structure) 
from native cellulases that evolution just has not found them yet and perhaps will never 
find them.  
In both of these scenarios, the first being that native cellulases are globally 
optimized and the second being that more efficient cellulases are extremely rare, any 
engineering approach will fail at discovering cellulases with higher catalytic activities. 
 
3.4.3  Limitations of the High-Throughput Avicel Screen 
Besides the obvious limitation that a whole cell screen may miss mutants that have 
increased specific activity but not increased whole cell activity, the high-throughput 
Avicel screen may suffer from other limitations. In particular it is well known that the 
rate of cellulose hydrolysis declines sharply as the reactions proceeds. Several 
explanations to this have been proposed including enzyme deactivation, product 
inhibition, decreases in substrate reactivity (presumably because the more accessible 
glycosidic bonds are hydrolyzed first), and the formation of unproductive and irreversible 
substrate-enzyme complexes [98,114]. It is possible that the differences reflecting 
changes in specific activity are more visible early on in the reaction as opposed to two 
hours into it when these inhibitory effects may have become significant. In other words, 
if there is fixed amount of substrate that can be hydrolyzed before the reaction rate slows 
down dramatically (as would be the case in most of the scenarios proposed to lead to a 
decrease in reaction rate), and the native enzymes take two hours to hydrolyze that fixed 
amount of substrate, even a significantly more efficient mutant, that could do it, in say, 
only five minutes, would not be selected by this screen. Unfortunately the most obvious 
solutions to this problem are not very practical (screening for shorter amounts of time or 
using significantly more substrate).  
However, the fact that all the parents, chimeras, and mutants that have been tested 
so far have almost identical specific activities on Avicel but not on PASC [53] suggests 
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that the current protocol of the Avicel screen may be inadequate for detecting differences 
in activity and that it may be worthwhile to investigate this further.  
 
3.5 Experimental Procedures 
3.5.1 Chimeras Construction and Generation of Random Mutagenesis 
Libraries Using Error-Prone PCR 
Details of chimera construction have been reported previously [53]. S. cerevisiae cells 
bearing the Cel6A plasmids were obtained from Dr. Heinzelman and Indira Wu from the 
California Institute of Technology. All plasmid DNA used for cloning purposes was 
extracted from S. cerevisiae cells using the ZYMOPREP yeast miniprep kit and 
transformed into E. coli. Transformed cells were allowed to grow overnight and then the 
plasmid DNA was extracted using the Qiagen Miniprep Kit. The Cel6A genes were 
sequenced using primers cellSeqFor (gtcgggtccgacttgctgtgcttccgg) located in the linker 
region 224 base pairs upstream of the CD and cellSeqRev (gcaacacctggcaattccttacc) 
located 108 base pairs downstream of the gene to ensure the presence of the correct gene. 
To generate random mutagenesis libraries using error-prone PCR, the gene segments 
coding for the CD were amplified using the forward primer cellCloneFor 
(ccaacgactattactcccagtgtcttc) located in the linker region 180 base pairs upstream of the 
CD and the reverse primer cellCloneRev (gacatgggagatcgaattcaactcc) located 47 base 
pairs downstream of the gene. Error-prone PCR was carried out in 100 µl total volume 
containing 100 ng DNA, 0.2 µM of each primer, 10 µl of 10X Roche PCR buffer, 10 µl 
of 55 mM MgCl2, 200 µM of dATP, 200 µM of dGTP, 500 µM of dTTP, 500 µM of 
dCTP, MnCl2 (50-400 µM), 5 units of Roche Taq DNA polymerase. Libraries with 
MnCl2 concentrations ranging from 50 to 400 µM were prepared for four chimeric and up 
to three native Cel6As. To reduce mutational bias across libraries with an equal 
concentration of MnCl2 but different templates, PCR master mixes were prepared 
containing the primers, the PCR buffer, the nucleotides and the MgCl2. This master mix 
was then divided into x tubes corresponding to the x concentrations of MnCl2 and to each 
tube the appropriate amounts of MnCl2 and PCR water were added. Each of these tubes 
was then split into n tubes corresponding to the p parental and the n-p chimeric Cel6As to 
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which template DNA and Taq DNA polymerase were added. The PCR program was 
95°C for 30 s, and then 20 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 2 min, 
and then 72°C for 5 min. The mutated amplified DNA from each library was then gel 
purified and co-transformed with vector digested with the New England Biolabs (NEB) 
restriction enzymes Xho1 and Acc651 into S. cerevisiae using the homologous 
recombination protocol described in [117]. Transformed cells were then plated on SD-
URA agar plates. The SD-URA mix was purchased from MP-biomedicals. Selected 
clones from this library were sequenced with forward and reverse primers, cellSeqFor 
and cellSeqRev, respectively.  
 
3.5.2  Recombination of Best Mutants 
The best nine mutations selected from the library of chimera 12 were recombined by 
amplifying six fragments spanning the nine mutations and then assembling them using 
overlap extension PCR. The forward and reverse primers for the six fragments were 1) 
cellCloneFor and 12REV_T73A (gtagtagtagaaccaggtggaggcgycgcggagctcga), 2) 
12FOR_T73A (tcgagctccgcgrcgcctccacctggttctactactac) and 12REV_Y93N 
(tggattacctgaatwcgtagcggttcccg), 3) 12FOR_Y93N (cgggaaccgctacgwattcaggtaatcca) and 
12REV_D282E_P283L_N290D (ttgtaaacatytgcaaacagctgcgcagcgrgwtcctgatttg), 4) 
12FOR_D282E_P283L_N290D (caaatcaggawcycgctgcgcagctgtttgcaratgtttacaa) and 
12REV_V398A_S410P (ggagcagaagratcactcgttccatctgactctcctccgggttttrcccaaacgaa), 5) 
12FOR_V398A_S410P (ttcgtttgggyaaaacccggaggagagtcagatggaacgagtgatycttctgctcc) and 
12REV_N445Y_V440A (ggattggcgtwagtcagtaattgtrcaaaataagcttggaacc), and 6) 
12FOR_N445Y_V440A (ggttccaagcttattttgyacaattactgactwacgccaatcc) and  
CellCloneRev, respectively. The mutations carried by the primers are indicated in their 
names. The primers are degenerative and allow the inclusion of either the native or the 
mutated amino acid. The lengths of the six fragments are 139, 86, 615, 402, 160, and 126 
base pairs. Six PCR reactions were carried out in parallel in 100 µl total volume 
containing 50 ng of chimera 12 DNA, 200 µM of each dNTP, 0.2 µM each of the forward 
and reverse primers listed above, 2 units of NEB Phusion DNA polymerase, and 20 µl of 
5X Phusion HF buffer to amplify each fragment. The PCR program was 98°C for 30 s, 
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and then 30 cycles of 98°C for 10 s, 55°C for 20 s, and 72°C for 10 s, and then 72°C for 
10 min for fragments 1, 2, 5, and 6. The PCR program for fragments 3 and 4 were 
identical but had an elongation time of 10 s. Amplified fragments were gel purified and 
then reassembled in three steps (five PCR reactions). In the first step fragments 1 and 2 
and fragments 5 and 6 were assembled using primers cellCloneFor and 12REV_Y93N 
and 12FOR_V398A_S410P and cellCloneRev, respectively. The PCR reactions were 
carried out in 50 µl total volume containing 50 ng of each fragment, 200 µM of each 
dNTP, 0.2 µM each of the forward and reverse primers, 2 units of NEB Phusion DNA 
polymerase, and 10 µl of 5X Phusion HF buffer. The PCR program was the same as that 
used to generate the individual fragments with an elongation time of 10 s. The assembled 
fragments were gel purified and used for the next step of the assembly. In the second step 
the assembled fragments 1 and 2 were assembled with fragment 3 and the assembled 
fragments 5 and 6 were assembled with fragments 4 using the forward and reverse 
primers cellCloneFor and 12REV_D282E_P283L_N290D and 
12FOR_D282E_P283L_N290D and cellCloneRev, respectively. The PCR conditions and 
program were the same as in the previous assembly step but the elongation times were 30 
s. The assembled fragments were gel purified and used for the final assembly step in 
which assembled fragments 1, 2, and 3 were assembled with assembled fragments 4, 5, 
and 6 using forward and reverse primers cellCloneFor and cellCloneRev, respectively. 
The PCR conditions and program were identical to the previous assembly steps with an 
elongation time of 45 s. The final construct was gel purified and co-transformed with 
vector digested with Xho1 and Acc651 (NEB) into S. cerevisiae using the homologous 
recombination protocol described in [117]. The transformed cells were then plated on 
SD-URA agar plates. Selected clones from this library were sequenced with forward and 
reverse primers, cellSeqFor and cellSeqRev, respectively.  
 
3.5.3 Addition of HIS6 Tags to Best Mutants from the Recombination 
Library 
PCR reactions were carried out to append a HIS6 tag to the C-terminus of the best mutants 
from the recombination library. The forward primer is located 421 base pairs upstream of 
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the CD domain and includes the Nhe1 restriction site (gctgaagctgtcatcggttacttag) and the 
reverse primer has a HIS6 over hang, the Acc651 restriction site, and a stop codon 
(ctgcaggtaccctaatggtggtgatggtgatgtagaaaactaggattggcgttagtcag). The PCR reactions were 
carried out in 50 µl total volume containing 50 ng of DNA, 0.2 µl of each the forward 
and reverse primer, 200 µM of each dNTP, 2 units of Phusion DNA polymerase and 10 
µl of 20X HF Phusion buffer. The PCR program was 98°C for 30 s, and then 30 cycles of 
98°C for 10 s, 55°C for 20 s, and 72°C for 60 s, and then 72°C for 10. Amplified DNA 
was digested using NEB dpn1, gel purified, and then digested using NEB restrictions 
enzymes Nhe1 and Acc651. The vector was prepared by digesting the plasmid bearing 
the gene of chimera 89 with the same restriction enzymes (Nhe1 and Acc651) and then 
by gel-purifying it. Vector and PCR inserts were ligated using NEB T4 ligase at 16°C for 
16 hours. The ligation mixture was purified using the QIAGEN DNA purification kit and 
then transformed into E. coli cells and plated on LB plates and allowed to grow 
overnight. Individual colonies were then picked and grown overnight in 5 ml of LB 
media supplemented with ampicillin, and then the plasmid DNA was extracted using the 
QIAGEN miniprep kit and sequenced using primers cellSeqFor and cellSeqRev to ensure 
correct incorporation of the HIS6 tag. Plasmids were then transformed into S. cerevisiae 
cells using the Zymo EZ frozen yeast transform kit and plated on SD-URA plates.  
 
3.5.4 Protein Expression  
Cells were grown for 72 hours at 30°C on SD-URA agar plates and then individual 
colonies were used to inoculate 96-well plates containing 50 µl of SD-URA media. Cells 
were allowed to grow overnight at 30°C and 250 RPM in a Kuhner shaker and were then 
expanded by adding 350 µl of YPD media (10 g yeast extract, 20 g peptone, and 20 g 
dextrose in 1 L of water). Cells were allowed to grow an additional 48 hours at 30°C and 
250 RPM and were then centrifuged and the supernatant used for the high-throughput 




3.5.5  Protein Purification 
Protein purification was achieved by growing cells for 72 hours at 30°C on SD-URA agar 
plates and then inoculating 5 ml of SD-URA media with a single colony. The cell culture 
was allowed to reach saturation overnight and then expanded by adding it to 50 ml of 
YPD media in Tunair flasks purchased from IBI Scientific. The cultures were then 
centrifuged, and the supernatant filtered using VWR 0.2 µm Nalgene filters. 500 µl of 
100 mM phenylmethanesulfonylfluoride (PMSF), 500 µl of 2% NaN3, and 50 µl of 10 M 
NaOH were then added to the sample to inhibit protease activity, preserve the sample, 
and improve binding to the column, respectively. The sample was then purified using a 1 
ml HisTrap HP column precharged with nickel (GE Healthcare) and an AKTA purifier 
FPLC system (GE Healthcare). The binding buffer was composed of 20 mM Tris, 100 
mM NaCl, and 10 mM imidazole at pH 8.0. The elution buffer was composed of 20 mM 
Tris, 100 mM NaCl, and 300 mM imidazole at pH 8.0. First, the column was equilibrated 
with five column volumes (cv) of binding buffer. Then, the sample was injected and 
washed with another seven cvs of binding buffer. Sample elution was achieved with a 
linear gradient. The proteins eluted at a concentration of about 100 mM imidazole. Buffer 
exchange was performed using SARTORIUS STEDIM 10,000 mwco VIVASPIN 
columns. The purified proteins were concentrated to about 500 µl in 50 mM sterile 
sodium acetate buffer at pH 5.0. An additional 5 µl of 100 mM PMSF and 5 µl of 2% 
NaN3 were then added, and the purified protein was stored at 4°C. The presence of a band 
at about 55 kDa on an SDS PAGE gel verified the presence of the correct protein. The 
concentration of the purified protein was determined by adding different amounts of the 
purified protein to 1 ml of a solution composed of 6 M guanidine hydrochloride and 25 
mM Na2HPO4 at pH 6.5 and measuring the absorption at 280 nm (A280). Once a linear 
relationship was observed between the amount of added sample and the A280, the 
concentration of the proteins was calculated using an extinction coefficient of  




3.5.6  High-Throughput Avicel Activity Assays 
An Avicel slurry containing 50 mg/ml of Avicel and 134 mM NaCl was stirred until it 
was visually homogenous. While still stirring, 60 µl of this slurry were added to PCR 
plates (TemPlate III 96-well, half skirted, 0.2 ml, thin wall, standard depth, and rimmed 
well, USA Scientific) with the aid of an 8-channel RAININ multichannel pipettor. 100 µl 
of protein supernatant were transferred from the 96-well culture plate to the PCR plate 
containing Avicel with the aid of a pipetting robot (Multimek 96 automated pipettor). The 
plates were then covered and placed at 4°C for 90 min to allow the enzymes to bind to 
the Avicel. The plates were then centrifuged to allow the Avicel and bound enzyme to 
settle at the bottom of the PCR plate wells. With the aid of the robot the supernatant was 
removed taking care not to disrupt the Avicel-enzyme pellet. With the aid of the pipetting 
robot, 180 µl of 50 mM sterile sodium acetate buffer pH 5.0 was then added to the pellet. 
The purpose of this step is to remove the sugars present from the growth media that 
would otherwise interfere with the reducing sugar assay. The centrifugation and wash 
steps were repeated four times. On the fourth time, the bound enzyme was re-suspended 
in 75 µl of 50 mM sterile sodium acetate buffer pH 5.0, the plates were sealed with 
Biorad microseal B film PCR sealers, and the reaction was initiated by placing the PCR 
plates in a Fisher Scientific Isotemp 220 water bath at 50°C. After two hours the plates 
were placed for ten min on ice to quench the reaction. The plates were then centrifuged 
and 50 µl of the supernatant were transferred to a new PCR plate to perform the Nelson-
Somogy reducing sugar assay [107,108]. Somogyi reagent was prepared by mixing 4.8 
ml of Somogyi reagent 1 with 1.2 ml of Somogyi reagent 2 per plate and then adding 50 
µl of this solution to each well of the PCR plates with the aid of a 12-channel RAININ 
multichannel pipettor. Somogyi reagent 1 was prepared by dissolving 72 g of Na2SO4, 6 g 
of potassium sodium tartrate tetrahydrate (Rochelle salt), 12 g of Na2CO3, and 8 g of 
NaHCO3 in 400 ml of ddH20. The solution was then filtrated using a VWR 0.2 µm 
Nalgene filter for sterilization purposes. Somogyi reagent 2 was prepared by dissolving 
18 g of Na2SO4, 2 g of CuSO4•5H20 in 100 ml of ddH20. The solution was then filtrated 
using a VWR 0.2 µm Nalgene filter for sterilization purposes. Somogyi reagents 1 and 2 
were prepared in advance and stored at room temperature. The plates were then sealed 
with Biorad microseal B film PCR sealers and placed at 98°C in a Fisher Scientific 
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Isotemp 220 water bath for 15 min. The plates were then allowed to cool on ice for 15 
min, and then 50 µl of Nelson reagent was added to each well with the aid of a RAININ 
multichannel pipettor. The Nelson reagent was prepared by dissolving 25 g of ammonium 
molybdate in 450 ml of ddH20 in a glass bottle wrapped in aluminum foil to protect the 
solution from light. 21 ml of concentrated H2SO4 were then added to the solution. 3 g of 
Na2H arsenate were dissolved in 25 ml of ddH20 and then added to the ammonium 
molybdate-H2SO4 solution. The solution was incubated at 37°C for 24 hours and then 
filtrated for sterilization purposes. The Nelson reagent was stored in the dark at room 
temperature. The plates were then centrifuged to remove the air bubbles. The pipetting 
robot was then used to thoroughly mix the PCR wells by pipetting and dispensing several 
times. 100 µl of the reaction mixture were then transferred to 96-well assay plates and the 
absorbance at 520 nm was measured. The amount of released cellobiose was determined 
using a calibration curve constructed with a cellobiose standard.  
 
3.5.7  Measurement of Avicel Specific Activity 
Reactions were carried out in 100 µl total volume, 300 nM purified protein, 50 mg/ml 
Avicel, and 80 mM NaCl. Each protein was assayed six times in six wells of a PCR plate. 
The PCR plate was kept on ice as the components of the reaction were being added and 
was then sealed with Biorad microseal B film PCR sealers. The reaction was initiated by 
placing the PCR plate in a Fisher Scientific Isotemp 220 water bath at 50°C for two 
hours. After two hours the PCR plate was placed on ice for 10 min to quench the 
reaction. The plates were then centrifuged and 50 µl of the supernatant were then 
transferred to a new PCR plate and Avicel activity was measured using the Nelson-
Somogyi method as described in section 3.5.6. 
 
3.5.8  Determination of Initial Rate of Reaction on Avicel 
The initial rate of reaction of purified proteins was determined using the Park-Johnson 
(PJ) assay [106]. There are three PJ reagents. PJ reagent A is made by dissolving 0.5 g of 
K3Fe(CN)6 and 34.84 g of K2HPO4 into 1 L of ddH20, then adjusting the pH to 10.6 and 
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then filtrating the solution using a VWR 0.2 µm Nalgene filter for sterilization purposes. 
PJ reagent B is made by dissolving 2.65 g of Na2CO3 and 0.325 g of KCN into 500 ml of 
ddH2O and then filtrating the solution for sterilization purposes. PJ reagent C is make by 
adding 2.5 g of Fe(III)Cl3, 10 g of polyvinylpyrrolidone, and 56.4 ml of H2SO4 into 1 L of 
ddH20 and then filtrating the solution for sterilization purposes. A slurry containing 10 
mg/ml of Avicel and 134 mM NaCl was prepared and heated in an Eppendorf 
thermomixer set to 50°C for 1 hour. Enzyme was then added to the tube to reach a final 
concentration of 300 nM in a volume of 600 µl. The sample was immediately vortexed 
and 100 µl were removed and placed into another tube kept on ice. This corresponds to 
the first time point. This procedure was repeated 5 more times in intervals of 30 seconds 
to finish the 600 µl of solution. The tubes containing the 100 µl aliquots were then 
centrifuged and 50 µl of the supernatant was transferred to a PCR plate. Then 100 µl of 
PJ reagent A and 50 µl of PJ reagent B were added to the sample and the PCR plate was 
sealed with Biorad microseal B film PCR sealers. It was then incubated at 95°C in a PCR 
thermocycler for 15 minutes, and then 180 µl of this were transferred to an assay plate 
containing 90 µl of PJ reagent C. The absorbance at 595 nm was read immediately and 
the amount of sugar formed determined using a calibration curve made with a cellobiose 
standard and the PJ assay.  
 
3.5.9  Stability Measurements 
In order to determine whether increases in specific activity were due to increases in 
thermostability some of the purified enzymes were incubated for 0, 3, 6, and 9 hours at 
50°C and then assayed for 2 hours at 30°C to determine whether enzyme denaturation 
was occurring under the assay conditions (50°C for 2 hours). A master mix of 550 µl 
containing 1.8 µM protein in 50 mM sodium acetate buffer pH 5.0 was prepared for each 
protein sample and then 100 µl of this solution were distributed to five separate 1.7 ml 
eppendorf tubes. Two of these tubes were placed on ice and the other three placed in a 
thermomixer at 50°C and stirred at 300 RPM for 3, 6, and 9 hours, respectively. Once a 
tube was removed from the thermomixer it was placed back on ice until all three tubes 
had completed their time at 50°C. At this point 60 µl of an Avicel slurry containing 50 
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mg/ml of Avicel and 134 mM NaCl was added to each of the tubes and they were then 
placed back in the thermomixer at 30°C at 300 RPM for 2 hours. After 2 hours the tubes 
were centrifuged and two 50 µl aliquots from each tube were placed in a PCR plate and 
the activity on Avicel measured as described in section 3.5.6. The amount of activity 
remaining relative to the sample that was kept on ice corresponds to the amount of 
protein that denatures at 50°C after the amount of time the tube was kept in the 
thermomixer at 50°C.  
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3.7 Supplementary Material 
Table 3.S1: Summary of the sequences and T50s of the 38 chimeras and two parental 
Cel6As used in the initial characterization performed to select the chimeras to mutate. 
The 8-digit chimera sequence specifies the parental origin of the blocks. 
chimera sequence T50 (°C) chimera sequence T50 (°C)  
Chimera 3 11332333 65.3 Chimera 68 13322332 69.8 
Chimera 12 22232132 68.0 Chimera 73 12111332 68.0 
Chimera 14 33213332 66.0 Chimera 75 12311332 69.5 
Chimera 15 23233133 61.0 Chimera 77 12131332 68.8 
Chimera 18 13231111 63.3 Chimera 78 13131332 70.0 
Chimera 20 12213111 63.3 Chimera 79 12331332 70.0 
Chimera 23 31311112 61.0 Chimera 81 12112332 68.0 
Chimera 35 22212231 62.0 Chimera 82 13112332 67.0 
Chimera 41 12133333 64.0 Chimera 84 13312332 70.0 
Chimera 42 13333232 67.3 Chimera 85 12132332 69.8 
Chimera 47 23311333 66.0 Chimera 86 13132332 70.5 
Chimera 48 33133132 65.0 Chimera 87 12332332 69.0 
Chimera HJ+ 12222332 71.3 Chimera 88 13332332 69.8 
Chimera 52 12112132 69.8 Chimera 89 11113332 70.0 
Chimera 53 12111131 69.3 Chimera 90 12113132 70.5 
Chimera 54 12132331 69.8 Chimera 91 13113132 70.0 
Chimera 55 12131331 68.8 Chimera 92 11111132 70.8 
Chimera 56 12332331 66.8 Chimera 93 11112132 70.3 
Chimera 60 13332331 69.5 P1 11111111 64.8 























Figure 3.S1: Purification profile of chimera 12, parent P3C311S, and a selected set of 



















Figure 3.S2: SDS-PAGE gels of purified chimera 12, parent P2C311S (P2), the top 
mutants from the recombination library, 2C, 3D, 6D, 7D, 7G, and 8E, and the top mutant 
from the error-prone library, P8F9. Chimera 12, parent P2C311S (P2), and 6D were 





Figure 3.S3: Linear curves used to estimate the concentration of the purified proteins 




















Figure 3.S4: Average E and m of the six chimeras selected for their similarity in whole 
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